<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29662436</article-id>
<article-id pub-id-type="pmc">5890195</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00079</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Hypothesis and Theory</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Neuroglial Dialog Between Cannabinoids and Hemichannels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Labra</surname>
<given-names>Valeria C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/361334/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santibáñez</surname>
<given-names>Cristian A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/498664/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gajardo-Gómez</surname>
<given-names>Rosario</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/508967/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Díaz</surname>
<given-names>Esteban F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gómez</surname>
<given-names>Gonzalo I.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/497588/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Orellana</surname>
<given-names>Juan A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/100184/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Departamento de Neurología, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff>
<aff id="aff2"><sup>2</sup><institution>Centro de Investigación y Estudio del Consumo de Alcohol en Adolescentes</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ildikó Rácz, Universitätsklinikum Bonn, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Marie-Eve Tremblay, Laval University, Canada; Bruno Pierre Guiard, Université de Toulouse, France; David Ruskin, Trinity College, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Juan A. Orellana <email xlink:type="simple">jaorella@uc.cl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>79</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Labra, Santibáñez, Gajardo-Gómez, Díaz, Gómez and Orellana.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Labra, Santibáñez, Gajardo-Gómez, Díaz, Gómez and Orellana</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The formation of gap junctions was initially thought to be the central role of connexins, however, recent evidence had brought to light the high relevance of unopposed hemichannels as an independent mechanism for the selective release of biomolecules during physiological and pathological conditions. In the healthy brain, the physiological opening of astrocyte hemichannels modulates basal excitatory synaptic transmission. At the other end, the release of potentially neurotoxic compounds through astroglial hemichannels and pannexons has been insinuated as one of the functional alterations that negatively affect the progression of multiple brain diseases. Recent insights in this matter have suggested encannabinoids (eCBs) as molecules that could regulate the opening of these channels during diverse conditions. In this review, we discuss and hypothesize the possible interplay between the eCB system and the hemichannel/pannexon-mediated signaling in the inflamed brain and during event of synaptic plasticity. Most findings indicate that eCBs seem to counteract the activation of major neuroinflammatory pathways that lead to glia-mediated production of TNF-α and IL-1β, both well-known triggers of astroglial hemichannel opening. In contrast to the latter, in the normal brain, eCBs apparently elicit the Ca<sup>2+</sup>-activation of astrocyte hemichannels, which could have significant consequences on eCB-dependent synaptic plasticity.</p>
</abstract>
<kwd-group>
<kwd>astrocytes</kwd>
<kwd>cannabis</kwd>
<kwd>neurons</kwd>
<kwd>connexins</kwd>
<kwd>pannexins</kwd>
<kwd>synaptic transmission</kwd>
<kwd>neuroinflammation</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Comisión Nacional de Investigación Científica y Tecnológica<named-content content-type="fundref-id">10.13039/501100002848</named-content></funding-source>
<award-id rid="cn001">Fondo Nacional de Desarrollo Científico y Tecnológico: FONDECYT 1160710 and Programa de Investigación Asociativa (PIA): Grant Anillo de Ciencia y Tecnología ACT1411</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="221"></ref-count>
<page-count count="18"></page-count>
<word-count count="14073"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>Because neurons are the excitable cells responsible for the transmission of electrochemical impulses during major cognitive processes, they were considered for a long time the main functional units at the central nervous system (CNS; Navarrete and Araque, <xref ref-type="bibr" rid="B125">2010</xref>). Nonetheless, accumulating evidence in the last two decades has showed that other cell types may also play an active and highly coordinated role in multiple brain functions (Iadecola, <xref ref-type="bibr" rid="B79">2017</xref>). For example, microvascular endothelial cells are pivotal players in the neurovascular coupling, as they actively modulate both the local blood flow and transport across the blood-brain barrier (BBB), ensuring oxygen, glucose and metabolite supply on demand (Zhao et al., <xref ref-type="bibr" rid="B218">2015</xref>). At the other end, along with being the major population of glial cells in the CNS, astrocytes also are the gatekeepers of the BBB and govern synaptic transmission, ionic and transmitter homeostasis, as well as antioxidant and neurovascular responses, among other functions (Allen and Eroglu, <xref ref-type="bibr" rid="B4">2017</xref>). Although initially not considered an element of the chemical synapse, microglia are now recognized to have a broad spectrum of functions beyond their immune capabilities, ranging from neuronal pruning to synaptic plasticity (Li and Barres, <xref ref-type="bibr" rid="B95">2017</xref>). Because they are the primary source of inflammatory mediators during infections, injuries and chronic neurodegenerative diseases, microglia finely control the inflammatory profile of astrocytes and decidedly impact the functions and fate of neurons (Kettenmann et al., <xref ref-type="bibr" rid="B88">2011</xref>). Most of the abovementioned functions and features tightly depend on the complex interaction and intercellular synchronization among brain cells. In mammals, cell-to-cell communication is in part mediated by two unrelated families of plasma membrane proteins: connexins and pannexins (Wang et al., <xref ref-type="bibr" rid="B207">2013a</xref>; Decrock et al., <xref ref-type="bibr" rid="B49">2015</xref>).</p>
<p>Connexins encompass a broad protein family of 21 members in humans (20, 37 and 17 in mice, zebrafish and frog, respectively), whose major structural features include the presence of four highly conserved transmembrane domains, two extracellular loops, intracellular N- and C-termini and a cytoplasmic loop linking the second and third transmembrane segments (Esseltine and Laird, <xref ref-type="bibr" rid="B57">2016</xref>; Figure <xref ref-type="fig" rid="F1">1</xref>). These proteins form two types of functional plasma membrane channels: hemichannels and gap junction channels (GJCs). Each hemichannel is the assembly of six connexins around a central aqueous pore that allow the bidirectional flux of ions and molecules between the intracellular and intracellular milieu (Sáez et al., <xref ref-type="bibr" rid="B168">2010</xref>; Figure <xref ref-type="fig" rid="F1">1</xref>). Additionally, hemichannels may diffuse freely to areas of cell-to-cell contact to align and dock with compatible hemichannels from a neighboring cell to complete the formation of GJCs. The arrangement and clustering of hundreds of GJCs at membrane appositions constitute the gap junction plaque, which provide a pathway of direct cytoplasmic communication between adjacent cells (Sáez et al., <xref ref-type="bibr" rid="B167">2003</xref>). These channels are the building blocks of the electrically conductive link between two neighboring neurons (electrical synapse), as well as the functional syncytium of coupled astrocytes that underlie the homeostatic regulation of ions, transmitters and metabolites at the CNS (Orellana et al., <xref ref-type="bibr" rid="B140">2009</xref>; Decrock et al., <xref ref-type="bibr" rid="B49">2015</xref>). For example, the essential architecture of electrically coupled retinal circuits rely on the communication through GJCs, as they are broadly found in all cell types of the retina (Bloomfield and Volgyi, <xref ref-type="bibr" rid="B24">2009</xref>). While the formation of gap junctions was initially thought to be the central role of connexins, the last decade had brought to light the high relevance of unopposed hemichannels as independent mechanisms for the selective release of relevant biomolecules (e.g., ATP, glutamate, PGE<sub>2</sub>) during physiological and pathological conditions (Giaume et al., <xref ref-type="bibr" rid="B70">2013</xref>; Montero and Orellana, <xref ref-type="bibr" rid="B121">2015</xref>; Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Basic structure of connexin and pannexin-based channels. Connexins and pannexins share a similar membrane topology with four α-helical transmembrane domains connected by two extracellular loops and one cytoplasmic loop; both the amino- and carboxy-termini are intracellular. The relative positions of the extracellular loop cysteines (green balls) and glycosylated asparagines (blue branches) are also shown. Hemichannels (also known as connexons) are formed by the oligomerization of six subunit connexins around a central pore. Pannexons are single membrane channels that are composed of six pannexin subunits. Recently, a band pattern more consistent with an octamer than a hexamer was observed in Panx2 by cross-linking studies and native gels of purified homomeric full-length and C-terminal truncation mutants (Ambrosi et al., <xref ref-type="bibr" rid="B7">2010</xref>). Under resting conditions, hemichannels and pannexons remain preferentially closed, but they may be activated by diverse physiological and pathological conditions and offer a diffuse transmembrane route between the intra- and extracellular milieu. Hemichannels dock each other to form functional cell-to-cell channels termed gap junction channels (GJCs). GJCs aggregate in well-known anatomical structures called gap junctions to facilitate the intercellular cytoplasmic exchange of metabolites, second messengers and ions.</p>
</caption>
<graphic xlink:href="fnmol-11-00079-g0001"></graphic>
</fig>
<p>Pannexins, on the other hand, belong to a three-member family of chordate proteins homologous to the invertebrate gap junction proteins: the innexins (Bruzzone et al., <xref ref-type="bibr" rid="B29">2003</xref>). Pannexins, unlike innexins and connexins, seem to have lost the capacity to directly couple contacting cells and thereby, the molecular and ionic interchange between the cytoplasmic and extracellular space is today widely recognized as their fundamental function. Although these proteins share some structural and topological features with connexins, their amino acid sequence and major post-translational modifications totally differ (Dahl and Keane, <xref ref-type="bibr" rid="B45">2012</xref>). Single pannexin channels, also known as pannexons, allow the release of different paracrine molecules, including ATP, UTP, D-serine and glutamate (Bond and Naus, <xref ref-type="bibr" rid="B27">2014</xref>). Pannexons formed by Pannexin 1 (Panx1), the most ubiquitous member of its family, are activated through direct protein-to-protein interactions with P2X<sub>7</sub> receptors (P2X<sub>7</sub>R; Locovei et al., <xref ref-type="bibr" rid="B97">2007</xref>), whereas the P2Y receptor (P2YR)-mediated rise in intracellular free Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>i</sub>) causes similar effects in these channels (Locovei et al., <xref ref-type="bibr" rid="B98">2006</xref>). Consequently, the crosstalk between pannexons and purinergic receptors has been proposed to be crucial for the paracrine ATP release and amplification of cell-to-cell Ca<sup>2+</sup> signaling (Wang et al., <xref ref-type="bibr" rid="B207">2013a</xref>; Dahl, <xref ref-type="bibr" rid="B44">2015</xref>). The latter is particularly true for astrocytes. They can communicate each other and with neurons by the spread of Ca<sup>2+</sup> waves through two major interdependent mechanisms. One of them requires the physical interaction among contacting astrocytes and involves the diffusion through GJCs of cytoplasmic Ca<sup>2+</sup>-mobilizing second messengers such as IP<sub>3</sub>, cADP-ribose (cADPR) or Ca<sup>2+</sup> itself (Scemes and Giaume, <xref ref-type="bibr" rid="B176">2006</xref>; Orellana et al., <xref ref-type="bibr" rid="B141">2012b</xref>). Alternatively, ATP produced by astrocytes may diffuse in a paracrine way to activate P2XRs/P2YRs, increasing the [Ca<sup>2+</sup>]<sub>i</sub> and perpetuating the propagation of Ca<sup>2+</sup> waves as new ATP is released into the extracellular space (Guthrie et al., <xref ref-type="bibr" rid="B75">1999</xref>; Anderson et al., <xref ref-type="bibr" rid="B8">2004</xref>). This mechanism of ATP-induced ATP release constitutes a critical pathway through which astrocytes exert their modulatory actions over neuronal activity (Chen et al., <xref ref-type="bibr" rid="B33">2013</xref>; Shen et al., <xref ref-type="bibr" rid="B178">2017</xref>).</p>
<p>Throughout the CNS there is a complex pattern of expression for connexins and pannexins, being highly dependent on developmental stage, brain region, cell type and brain homeostatic conditions (Söhl et al., <xref ref-type="bibr" rid="B186">2000</xref>; Koulakoff et al., <xref ref-type="bibr" rid="B91">2012</xref>; Gaete et al., <xref ref-type="bibr" rid="B64">2014</xref>; Swayne and Bennett, <xref ref-type="bibr" rid="B196">2016</xref>). Up to now, most studies indicate that hemichannels and pannexons play pivotal roles at the normal CNS, including the establishment of adhesive interactions, tolerance to ischemia, fear memory consolidation, glucose and redox sensing, chemoreception, BBB permeability, spontaneous electrical activity, synaptic transmission and neuronal migration (Orellana et al., <xref ref-type="bibr" rid="B137">2016</xref>). Nevertheless, during acute and chronic brain damage, these channels behave abnormally, showing an increased activity and altering their permeability properties to different crucial biomolecules. The latter phenomenon has been hypothesized as a common hallmark reflecting the homeostatic unbalance observed in diverse neuropathological conditions such as Alzheimer’s disease (AD), epilepsy, ischemia and HIV-associated neurological disorders (Domercq et al., <xref ref-type="bibr" rid="B54">2010</xref>; Orellana et al., <xref ref-type="bibr" rid="B134">2011a</xref>; Decrock et al., <xref ref-type="bibr" rid="B49">2015</xref>; Berman et al., <xref ref-type="bibr" rid="B21">2016</xref>; Robel and Sontheimer, <xref ref-type="bibr" rid="B161">2016</xref>; Giaume et al., <xref ref-type="bibr" rid="B71">2017</xref>). While the mechanisms linked to hemichannel/pannexon dysfunction remain still obscure, some clues coming from recent studies argue in favor of the involvement of inflammatory and redox signaling in this process (Takeuchi et al., <xref ref-type="bibr" rid="B198">2006</xref>; Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>; Karpuk et al., <xref ref-type="bibr" rid="B85">2011</xref>; Adamson and Leitinger, <xref ref-type="bibr" rid="B2">2014</xref>; Retamal, <xref ref-type="bibr" rid="B158">2014</xref>; Avendaño et al., <xref ref-type="bibr" rid="B15">2015</xref>). The release of potentially neurotoxic compounds through hemichannels and pannexons has been insinuated as one of the functional alterations that negatively impact the progression of multiple brain diseases, turning the study and comprehension of this field in something of high relevance (Shestopalov and Slepak, <xref ref-type="bibr" rid="B181">2014</xref>; Kim et al., <xref ref-type="bibr" rid="B89">2016</xref>; Giaume et al., <xref ref-type="bibr" rid="B71">2017</xref>; Malik and Eugenin, <xref ref-type="bibr" rid="B104">2017</xref>; Rovegno and Sáez, <xref ref-type="bibr" rid="B164">2018</xref>). Accordingly, many research groups are currently focused in developing new therapeutic and pharmacological tools to tackle the exacerbated activity of hemichannels and pannexons (Moore and O’Brien, <xref ref-type="bibr" rid="B122">2015</xref>; Becker et al., <xref ref-type="bibr" rid="B18">2016</xref>; Willebrords et al., <xref ref-type="bibr" rid="B212">2017</xref>). Recent insights in this matter have suggested cannabinoids (CBs) as molecules that could counteract the opening of hemichannels and pannexons during neuroinflammatory conditions (Froger et al., <xref ref-type="bibr" rid="B63">2009</xref>; Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>). In this review, we first describe major features of the brain endocannabinoid (eCB) system and its critical role in synaptic transmission. Later, the possible neuroprotective actions of eCBs are discussed, in particular, the inhibition of the uncontrolled opening of glial cell hemichannels. Finally, we hypothesize how astroglial hemichannels may participate in eCB-mediated synaptic transmission in the healthy brain.</p>
</sec>
<sec id="s2">
<title>The Endocannabinoid System at the CNS</title>
<p>Although cannabis (<italic>Cannabis sativa</italic>) has been widely used throughout history for medicinal, religious, recreational and social purposes, just in the past two decades research in the field has brought to light its multiple benefits (Corcos et al., <xref ref-type="bibr" rid="B39">2005</xref>; Biswas et al., <xref ref-type="bibr" rid="B23">2017</xref>; Mahvan et al., <xref ref-type="bibr" rid="B103">2017</xref>; Yassin et al., <xref ref-type="bibr" rid="B214">2017</xref>). In 1964, tetrahydrocannabinol (THC), the principal psychoactive constituent of cannabis, was isolated and purified, permitting the elucidation of its chemical structure (Gaoni and Mechoulam, <xref ref-type="bibr" rid="B67">1964</xref>). Since then, many studies have been conducted to reveal the molecular mechanisms responsible for the psychoactive effects of cannabis-derived compounds, also known as phytocannabinoids (Zuardi, <xref ref-type="bibr" rid="B220">2008</xref>). Late in the 1980s, as a result of decades of research on THC, Devane et al. (<xref ref-type="bibr" rid="B51">1992b</xref>) discovered the binding sites for the first CB receptor in the brain: CB<sub>1</sub>. Shortly after the cloning of the CB<sub>1</sub> receptor (Matsuda et al., <xref ref-type="bibr" rid="B111">1990</xref>), a second receptor called CB<sub>2</sub> was isolated from human promyelocytic leukemia cells (Munro et al., <xref ref-type="bibr" rid="B123">1993</xref>), whereas two eCBs agonists were identified: anandamide or N-arachidonoylethanolamine (AEA) and 2-arachidonylglycerol (2-AG; Devane et al., <xref ref-type="bibr" rid="B50">1992a</xref>; Sugiura et al., <xref ref-type="bibr" rid="B195">1995</xref>). Up to now, several molecules encompass the current thirteen-member list of eCBs (Pertwee, <xref ref-type="bibr" rid="B148">2015</xref>), including O-arachidonoyl ethanolamine (Porter et al., <xref ref-type="bibr" rid="B150">2002</xref>) and 2-arachidonyl glyceryl ether (Hanus et al., <xref ref-type="bibr" rid="B77">2001</xref>); nevertheless, most studies have been focalized on AEA and 2-AG. Whether plant derived, synthetic or endogenous, CBs are lipid messengers that activate at least two G<sub>i/o</sub> protein-coupled receptors; CB<sub>1</sub> and CB<sub>2</sub>; and one ionotropic receptor: the transient receptor potential vanilloid 1 (TRPV1; Zygmunt et al., <xref ref-type="bibr" rid="B221">1999</xref>). AEA predominantly acts as partial agonist of both CB<sub>1</sub> and CB<sub>2</sub> receptors and shows less relative intrinsic efficacy and affinity for CB<sub>2</sub> than for CB<sub>1</sub> receptors (Pertwee, <xref ref-type="bibr" rid="B146">2010</xref>). On the other hand, 2-AG binds with the same affinity to both receptors and exhibits higher potency than AEA as CB<sub>1</sub> and CB<sub>2</sub> receptor agonist (Pertwee, <xref ref-type="bibr" rid="B146">2010</xref>). AEA also binds and activates TRPV1s (Zygmunt et al., <xref ref-type="bibr" rid="B221">1999</xref>), whereas 2-AG also binds GABA<sub>A</sub> receptors (Sigel et al., <xref ref-type="bibr" rid="B183">2011</xref>). In concert, eCBs, their receptors and regulatory synthetic (N-acylphosphatidylethanolamine phospholipase D [NAPE-PLD] and diacyglyerol lipase α [DAGLα]) and catabolic (fatty acid amide hydrolase [FAAH], monoacylglycerol lipase [MAGL] and others) enzymes constitute the triad usually referred as the eCB system (Battista et al., <xref ref-type="bibr" rid="B16">2006</xref>). This systemic pathway plays key homeostatic functions in the CNS, as well as in multiple peripheral sites including skin, cardiovascular system, gastrointestinal tract, adipose tissue and liver (Pertwee, <xref ref-type="bibr" rid="B147">2012</xref>).</p>
<p>At the CNS, AEA originates from the metabolism of NAPE by the activity of NAPE-PLD, being this process dependent on rising [Ca<sup>2+</sup>]<sub>i</sub> upon depolarization and/or activation of ionotropic receptors (Luchicchi and Pistis, <xref ref-type="bibr" rid="B101">2012</xref>). The biosynthesis of 2-AG from triacylglycerols requires the action of DAGL triggered by the activation of metabotropic receptors coupled to the PLCβ (Kreitzer and Regehr, <xref ref-type="bibr" rid="B94">2002</xref>). Once postsynaptic neurons release eCBs into the synaptic cleft, they diffuse in a retrograde manner to activate presynaptic G<sub>i/o</sub>-coupled CB<sub>1</sub> receptors, which result in the hyperpolarization of presynaptic terminals and as a consequence decreases neurotransmitter release (Ohno-Shosaku et al., <xref ref-type="bibr" rid="B130">2001</xref>). The latter occurs at least by two major mechanisms of synaptic depression. At one end, short-term stimulation of CB<sub>1</sub> receptors may lead to presynaptic inhibition of Ca<sup>2+</sup> influx through N- and P/Q-type voltage-gated Ca<sup>2+</sup> channels (Kreitzer and Regehr, <xref ref-type="bibr" rid="B94">2002</xref>; Nimmrich and Gross, <xref ref-type="bibr" rid="B128">2012</xref>), or activation of presynaptic A-type and inward rectifier K<sup>+</sup> channels (Kreitzer and Regehr, <xref ref-type="bibr" rid="B94">2002</xref>). At the other end, long-term activation of CB<sub>1</sub> receptors may blunt the function of adenylyl cyclase (Childers and Deadwyler, <xref ref-type="bibr" rid="B37">1996</xref>), resulting in the subsequent reduction of presynaptic cAMP levels and PKA activity (Chevaleyre et al., <xref ref-type="bibr" rid="B35">2007</xref>). Synaptic signaling of eCBs ceases with their re-uptake and subsequent intracellular degradation. Inactivation of AEA takes place primarily by action of FAAH (Cravatt et al., <xref ref-type="bibr" rid="B41">1996</xref>), whereas 2AG is degraded by the presynaptic enzyme MAGL and α/β-Hydrolase domain-containing 6 (Dinh et al., <xref ref-type="bibr" rid="B53">2002</xref>; Marrs et al., <xref ref-type="bibr" rid="B106">2010</xref>). Additionally, eCBs can act as non-retrograde messengers, where 2-AG may stimulate postsynaptic CB<sub>1</sub> or CB<sub>2</sub> receptors, whereas AEA may open postsynaptic TRPV1s (Castillo et al., <xref ref-type="bibr" rid="B32">2012</xref>).</p>
<p>Most of the psychoactive effects of cannabis depend on CB<sub>1</sub> receptors and their vast expression on neurons throughout the brain, including the basal ganglia, cerebellar cortex and hippocampus (Moldrich and Wenger, <xref ref-type="bibr" rid="B117">2000</xref>). Despite of being characterized in some neurons (Onaivi, <xref ref-type="bibr" rid="B132">2011</xref>; Stempel et al., <xref ref-type="bibr" rid="B192">2016</xref>); CB<sub>2</sub> receptors seem mostly found in glial cells at the nervous system (see below) and immune cell in the periphery, such as macrophages, neutrophils, lymphocytes, natural killer cells and monocytes (Galiègue et al., <xref ref-type="bibr" rid="B66">1995</xref>; Buckley et al., <xref ref-type="bibr" rid="B30">2000</xref>; Núñez et al., <xref ref-type="bibr" rid="B129">2004</xref>). What remained as an open question for a long time is whether glial cells actually express CB receptors. Although early studies described the presence of CB<sub>1</sub> and CB<sub>2</sub> receptors in astrocytomas and primary astroglial cultures (Bouaboula et al., <xref ref-type="bibr" rid="B28">1995</xref>; Sánchez et al., <xref ref-type="bibr" rid="B172">1998</xref>; Molina-Holgado F. et al., <xref ref-type="bibr" rid="B119">2002</xref>; Sheng et al., <xref ref-type="bibr" rid="B179">2005</xref>), other studies did not find CB receptors in astrocytes (Sagan et al., <xref ref-type="bibr" rid="B169">1999</xref>; Walter and Stella, <xref ref-type="bibr" rid="B205">2003</xref>; Lou et al., <xref ref-type="bibr" rid="B99">2012</xref>). In microglia, first reports showed an important expression of CB<sub>2</sub> receptors in primary cultures and cell lines from different species (Carlisle et al., <xref ref-type="bibr" rid="B31">2002</xref>; Facchinetti et al., <xref ref-type="bibr" rid="B58">2003</xref>; Klegeris et al., <xref ref-type="bibr" rid="B90">2003</xref>; Walter et al., <xref ref-type="bibr" rid="B206">2003</xref>; Ramírez et al., <xref ref-type="bibr" rid="B155">2005</xref>), however, CB<sub>1</sub> receptors were rarely detected (Waksman et al., <xref ref-type="bibr" rid="B203">1999</xref>). These contradictory results may reflect differences in the approaches used, including animal strains or species, antibody specificity and efficacy and cell conditions, as well as the fact that lower expression of CB receptors could make extremely difficult their identification by western blotting or immunohistochemistry (Onaivi et al., <xref ref-type="bibr" rid="B133">2012</xref>; Metna-Laurent and Marsicano, <xref ref-type="bibr" rid="B114">2015</xref>). In particular, several <italic>in vitro</italic> culture conditions influence glial function and inflammatory profile, such as type of isolation, culture medium, serum supplementation, medium changes, confluence, cell age, substrates and purity (Saura, <xref ref-type="bibr" rid="B175">2007</xref>; Codeluppi et al., <xref ref-type="bibr" rid="B38">2011</xref>; Stansley et al., <xref ref-type="bibr" rid="B188">2012</xref>; Bohlen et al., <xref ref-type="bibr" rid="B25">2017</xref>). Nowadays, most <italic>in vitro</italic> and <italic>in vivo</italic> evidence indicates that both astrocytes and microglia express CB<sub>1</sub> and CB<sub>2</sub> receptors in rodents (Gong et al., <xref ref-type="bibr" rid="B73">2006</xref>; Navarrete and Araque, <xref ref-type="bibr" rid="B124">2008</xref>; Palazuelos et al., <xref ref-type="bibr" rid="B143">2009</xref>; Sagredo et al., <xref ref-type="bibr" rid="B170">2009</xref>; Mecha et al., <xref ref-type="bibr" rid="B112">2015</xref>; Navarro et al., <xref ref-type="bibr" rid="B127">2018</xref>), dogs (Fernández-Trapero et al., <xref ref-type="bibr" rid="B59">2017</xref>) and humans (Benito et al., <xref ref-type="bibr" rid="B19">2005</xref>, <xref ref-type="bibr" rid="B20">2007</xref>), thus playing critical roles in immunomodulatory responses and synaptic plasticity (Di Marzo et al., <xref ref-type="bibr" rid="B52">2015</xref>; Oliveira da Cruz et al., <xref ref-type="bibr" rid="B131">2016</xref>).</p>
</sec>
<sec id="s3">
<title>Neuroprotective Actions of Cannabinoids Via the Inhibition of Hemichannels</title>
<p>Neuroinflammation is a pivotal determinant in the pathogenesis and progression of multiple acute and chronic neurodegenerative diseases. Microglial activation, reactive astrogliosis, production of inflammatory mediators (cytokines, chemokines, nitric oxide [NO], reactive oxygen and nitrogen species [ROS/RNS]), BBB breakdown and subsequent brain infiltration of circulating immune cells characterize this process (Becher et al., <xref ref-type="bibr" rid="B17">2017</xref>). Both microglial activation and reactive astrogliosis constitute graded and multistage conserved glial reactions that counteract acute damage, restoring the homeostasis and limiting the brain parenchyma injury (Kettenmann et al., <xref ref-type="bibr" rid="B88">2011</xref>; Pekny and Pekna, <xref ref-type="bibr" rid="B144">2014</xref>). Nevertheless, during severe challenges and chronic brain damage, microglia and astrocytes may turn in uncontrolled source of inflammatory mediators rather than exhibiting a repair-oriented activity profile. While an efficient immune response is necessary to resolve brain threats, under the above circumstances, astrocytes and microglia may worsen disease progression by altering synaptic function, ion homeostasis, antioxidant defense and neuronal survival.</p>
<p>A growing body of data support the idea that eCBs are endowed with powerful immunoregulatory and anti-inflammatory properties, influencing both the CNS and peripheral tissues (Walter and Stella, <xref ref-type="bibr" rid="B205">2003</xref>; Rom and Persidsky, <xref ref-type="bibr" rid="B162">2013</xref>; Turcotte et al., <xref ref-type="bibr" rid="B201">2015</xref>). eCBs and synthetic CB receptor agonists decrease the production of NO, ROS/RNS, free radicals and pro-inflammatory cytokines in activated glial cells, while facilitate the switching of dysfunctional microglia towards an anti-inflammatory phenotype (Waksman et al., <xref ref-type="bibr" rid="B203">1999</xref>; Molina-Holgado E. et al., <xref ref-type="bibr" rid="B118">2002</xref>; Molina-Holgado et al., <xref ref-type="bibr" rid="B120">2003</xref>; Sheng et al., <xref ref-type="bibr" rid="B179">2005</xref>; Mecha et al., <xref ref-type="bibr" rid="B112">2015</xref>). Remarkably, brain levels of eCBs and glial CB receptors increase during neuroinflammation and neurodegenerative conditions, which may reflect self-neuroprotective and adaptive processes aimed at limiting the deleterious effects of inflammatory responses. In this line, CBs have been proposed as therapeutic tools to tackle several brain pathologies such as AD, multiple sclerosis (MS), Huntington’s disease (HD), traumatic brain injury (TBI), Parkinson’s disease (PD), among others (Kendall and Yudowski, <xref ref-type="bibr" rid="B87">2016</xref>; Lu and Mackie, <xref ref-type="bibr" rid="B100">2016</xref>). Supporting this notion, CB administration greatly mitigates the symptoms generated in animal models of MS (Lyman et al., <xref ref-type="bibr" rid="B102">1989</xref>), HD (Palazuelos et al., <xref ref-type="bibr" rid="B143">2009</xref>) and AD (Ramírez et al., <xref ref-type="bibr" rid="B155">2005</xref>; Martín-Moreno et al., <xref ref-type="bibr" rid="B110">2012</xref>), as well as a well-characterized model of chronic neuroinflammation produced by the infusion of lipopolysaccharide (LPS; Marchalant et al., <xref ref-type="bibr" rid="B105">2007</xref>). Accumulating evidence suggests that neuroprotective actions of CBs depend on cellular and molecular events modulating the dysfunctional status of glial cells (Stella, <xref ref-type="bibr" rid="B190">2004</xref>, <xref ref-type="bibr" rid="B191">2010</xref>). At this point, one line of thought has argued that CBs may favor neuronal survival by inhibiting the uncontrolled activity of glial hemichannels and pannexons (Orellana et al., <xref ref-type="bibr" rid="B142">2012c</xref>).</p>
<p>Inflammation has been established as a corner stone in the impaired function of hemichannels and pannexons not only in the CNS but also in peripheral organs (Kim et al., <xref ref-type="bibr" rid="B89">2016</xref>; Crespo Yanguas et al., <xref ref-type="bibr" rid="B42">2017</xref>). Just in the last 3 years a large list of inflammatory agents have been shown to exacerbate the opening of these channels in glial cells, such as cytokines (Abudara et al., <xref ref-type="bibr" rid="B1">2015</xref>), growth factors (Garre et al., <xref ref-type="bibr" rid="B68">2016</xref>), LPS (Avendaño et al., <xref ref-type="bibr" rid="B15">2015</xref>), human immunodeficiency virus (Orellana et al., <xref ref-type="bibr" rid="B138">2014</xref>) and ultrafine carbon black particles (Wei et al., <xref ref-type="bibr" rid="B210">2014</xref>). Over the same period, similar findings have been found in multiple animal models of human disease, including amyotrophic lateral sclerosis (Almad et al., <xref ref-type="bibr" rid="B5">2016</xref>), AD (Yi et al., <xref ref-type="bibr" rid="B216">2016</xref>), hypercholesterolemia (Orellana et al., <xref ref-type="bibr" rid="B138">2014</xref>), traumatic injury (Rovegno et al., <xref ref-type="bibr" rid="B165">2015</xref>) and stress (Orellana et al., <xref ref-type="bibr" rid="B136">2015</xref>). The release of cytokines from activated microglia represents a fundamental mechanism of Cx43 hemichannel activation in astrocytes <italic>in vitro</italic> (Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>) and <italic>ex vivo</italic> (Abudara et al., <xref ref-type="bibr" rid="B1">2015</xref>). In healthy conditions, the expression and activity of these channels is not high, but enough to ensure the release and influx of relevantly biological substances (Orellana et al., <xref ref-type="bibr" rid="B137">2016</xref>). However, when astrocytes are cultured with primary microglia in presence of LPS, the opening of Cx43 hemichannels, determined from unitary current and dye uptake recordings, is prominently raised (Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>). The latter response is emulated with conditioned media (CM) harvested from LPS-stimulated primary microglia, bringing up the idea that soluble factors released by microglia modulate astrocyte hemichannels (Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>). ELISA, immunoneutralization and cytokine receptor blocking analysis reveal that IL-1β and TNF-α are indeed the soluble factors increasing Cx43 hemichannel opening in primary astrocytes (Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>), which is consistent with previous studies showing that both cytokines reduce Cx43 expression and coupling between astrocytes (Même et al., <xref ref-type="bibr" rid="B113">2006</xref>). Hence, IL-1β and TNF-α released by LPS-treated microglia regulate gap junctions and hemichannels in an opposing manner in cultured astrocytes (Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>).</p>
<p>With this in mind, Froger et al. (<xref ref-type="bibr" rid="B63">2009</xref>) investigated whether endogenous (methanandamide [Meth], a non-hydrolyzable analog of AEA) and synthetic (WIN-55,212-2 [WIN] and CP 55,940 [CP]) CBs could modulate the release of IL-1β and TNF-α from LPS-treated microglia and their opposite effects on astroglial GJC and hemichannel function. They found that WIN, CP or Meth suppress the release of TNF-α and IL-1β by LPS-treated primary microglia (Froger et al., <xref ref-type="bibr" rid="B63">2009</xref>), reinforcing previous reports describing that THC, as well as eCBs or synthetic CBs, blunt the expression and production of both cytokines in activated primary microglia (Puffenbarger et al., <xref ref-type="bibr" rid="B153">2000</xref>; Facchinetti et al., <xref ref-type="bibr" rid="B58">2003</xref>). More relevantly, these CBs prevented the astroglial uncoupling elicited by the following conditions: (i) LPS treatment in astrocyte-microglia primary mixed cultures; (ii) CM harvested from LPS-activated primary microglia; or (iii) mixture of IL-1β and TNF-α (Froger et al., <xref ref-type="bibr" rid="B63">2009</xref>). Particularly, these preventive effects occurred in an additive way, indicating that WIN, CP and Meth likely act on different CB receptors. Coincident with this line of though, CB<sub>1</sub> or CB<sub>2</sub> receptor blockers abrogated with distinct pharmacological profiles the counteracting actions of WIN and Meth (Froger et al., <xref ref-type="bibr" rid="B63">2009</xref>). The latter fit with the current notion of astrocytes expressing both CB<sub>1</sub> and CB<sub>2</sub> receptors (Benito et al., <xref ref-type="bibr" rid="B20">2007</xref>; Navarrete and Araque, <xref ref-type="bibr" rid="B124">2008</xref>; Sagredo et al., <xref ref-type="bibr" rid="B170">2009</xref>; Navarro et al., <xref ref-type="bibr" rid="B127">2018</xref>). In the same study, WIN and Meth were found to fully abolish the increase in Cx43 hemichannel activity in astrocytes triggered by the mixture of IL-1β and TNF-α (Froger et al., <xref ref-type="bibr" rid="B63">2009</xref>). Contrary to the preventive effects observed in astroglial uncoupling, the CB-mediated inhibition of hemichannel opening was not additive and depended only on the activation of CB<sub>1</sub> receptors (Froger et al., <xref ref-type="bibr" rid="B63">2009</xref>).</p>
<p>As indicated above, exacerbated opening of glial hemichannels or pannexons may lead to the release of potentially neurotoxic compounds, resulting in neuronal alterations and subsequent cell death. In a follow-up study, Froger et al. (<xref ref-type="bibr" rid="B62">2010</xref>) tested the contribution of Cx43 hemichannel opening to NMDA-induced excitotoxicity in neuron/astrocyte co-cultures after treatment with TNF-α and IL-β. NMDA treatment significantly increased neurotoxicity in cytokine-treated co-cultures compared to the untreated ones, whereas this response did not occur in neurons co-cultured with Cx43 knock-out astrocytes or in the presence of Cx43 hemichannel blockers (Froger et al., <xref ref-type="bibr" rid="B62">2010</xref>). At this point, the authors addressed the possibility that CB treatment could have a neuroprotective effect in NMDA and cytokine-induced excitotoxicity. Concordant with this notion, WIN completely prevented the increase in NMDA neurotoxicity produced by the mixture of TNF-α and IL-β (Froger et al., <xref ref-type="bibr" rid="B62">2010</xref>). In the same line, recent studies by Gajardo-Gómez et al. (<xref ref-type="bibr" rid="B65">2017</xref>) reported that CBs ameliorate the amyloid-β peptide (Aβ)-induced neuronal death by preventing the dysfunctional opening of Cx43 hemichannels in astrocytes. Using time-lapse measurements of ethidium uptake, as well as patch clamp recordings, they showed that WIN, 2-AG and Meth, fully neutralize the Aβ-induced Cx43 hemichannel opening in cultured astrocytes and acute hippocampal slices. These responses were accompanied with a significant decline of the Aβ-induced production of IL-1β, TNF-α and NO in astrocytes (Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>). Similar to that found by Froger et al. (<xref ref-type="bibr" rid="B63">2009</xref>), blockade of CB<sub>1</sub> receptors with SR-141716A completely prevented the counteracting action of WIN, 2-AG and Meth over the Aβ-induced Cx43 hemichannel opening in cultured astrocytes. CBs also improved neuronal survival by mitigating the Aβ-induced excitotoxic release of glutamate and ATP linked to the opening of astroglial Cx43 hemichannels (Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>). In discrepancy with primary cultures, in acute hippocampal slices the protective actions of WIN over hemichannel activity and neuronal death occurred via the activation of both CB<sub>1</sub> and CB<sub>2</sub> receptors, suggesting a cumulative action of CBs as they can act simultaneously in several cell types (Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>).</p>
<p>How CBs impede the opening of hemichannels during pro-inflammatory conditions? A decade ago, Retamal et al. (<xref ref-type="bibr" rid="B159">2006</xref>) demonstrated that NO increases the opening of Cx43 hemichannels in ischemic astrocytes by inducing the S-nitrosylation of surface Cx43. Such key covalent modification also seems crucial for the cytokine-dependent opening of astroglial Cx43 hemichannels, as the inhibition of iNOS completely suppress this response in several pathological conditions (Retamal et al., <xref ref-type="bibr" rid="B160">2007</xref>; Orellana et al., <xref ref-type="bibr" rid="B138">2014</xref>; Avendaño et al., <xref ref-type="bibr" rid="B15">2015</xref>; Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>). In similar scenarios, blocking of p38 MAP kinase mitigates the activity of these channels, which is consistent with the fact that this pathway is a well-established cytokine target that induces iNOS expression and subsequent NO production in astrocytes (Wang et al., <xref ref-type="bibr" rid="B209">2017</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>). Altogether, these data denote that CB-mediated counteracting actions on hemichannel function may primarily proceeds by decreasing cytokine production and p38 MAP kinase activation, resulting in the subsequent suppression of NO production (Figure <xref ref-type="fig" rid="F2">2</xref>). In this context, the suppressive action of CBs on the NF-κβ pathway should be crucial, as it controls multiple aspects of neuroinflammation, including activation of glial cells and production of inflammatory mediators such as cytokines and NO (Shih et al., <xref ref-type="bibr" rid="B182">2015</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>). According with this notion, CBs blunt NF-κβ activation and reduce the production of NO and both IL-1β and TNF-α, as well as the activation of p38 MAP kinase in astrocytes (Curran et al., <xref ref-type="bibr" rid="B43">2005</xref>; Sheng et al., <xref ref-type="bibr" rid="B180">2009</xref>; Aguirre-Rueda et al., <xref ref-type="bibr" rid="B3">2015</xref>), even in those stimulated with conditions that open hemichannels (e.g., Aβ; Aguirre-Rueda et al., <xref ref-type="bibr" rid="B3">2015</xref>). Noteworthy, inhibition of NO production appears to rely on both CB<sub>1</sub> and CB<sub>2</sub> receptors (Sheng et al., <xref ref-type="bibr" rid="B179">2005</xref>), while blockade of p38 MAP kinase activity is preferentially driven by CB<sub>2</sub> receptors (Sheng et al., <xref ref-type="bibr" rid="B180">2009</xref>). The latter may constitute a possible explication to the differential CB<sub>1</sub>/CB<sub>2</sub> receptor pharmacology of synthetic and endogenous CBs in diverse astrocyte functions. A second but complementary mechanism of hemichannel regulation to that resulting from posttranslational modifications (e.g., S-nitrosylation) is the sorting of hemichannels to the cell surface. For instance, WIN fully abolish the Aβ-induced augment in surface levels of Cx43, signifying that modifications in surface expression of this protein may account for the preventive effects of CBs (Gajardo-Gómez et al., <xref ref-type="bibr" rid="B65">2017</xref>). Future studies are required to elucidate the mechanisms associated to the CB-mediated regulation of surface Cx43.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Cannabinoids (CBs) prevent the opposite regulation of astroglial connexin-based channels evoked by inflammatory conditions. In activated microglia, endocannabinoids (eCBs) acting on CB<sub>1</sub>Rs/CB<sub>2</sub>Rs counteract the NF-κβ-dependent release of TNF-α and IL-1β (1). In addition, in activated astrocytes, the stimulation of CB<sub>1</sub>Rs could also blunt the NF-κβ-mediated autocrine/paracrine release of TNF-α and IL-1β (2) along with the corresponding activation of TNFR1 (3) and IL1RI/IL1RAcP (4). The latter results in the inhibition of p38 MAP kinase and nitric oxide (NO) production, as well as the consequent reduction in excitotoxic release of gliotransmitters (e.g., glutamate and ATP) through astroglial Cx43 hemichannels (5). In parallel, activation of CB<sub>1</sub>Rs/CB<sub>2</sub>Rs may neutralize the reduction in gap junction communication (6) evoked by pro-inflammatory conditions (7).</p>
</caption>
<graphic xlink:href="fnmol-11-00079-g0002"></graphic>
</fig>
</sec>
<sec id="s4">
<title>The Possible Crosstalk Between Astrocyte Hemichannels and Cannabinoid System During Synaptic Transmission and Plasticity</title>
<p>Without a doubt, the strategic alliance between neurons and astrocytes is crucial to understand the contemporary notion of synaptic transmission and plasticity (Araque et al., <xref ref-type="bibr" rid="B10">2014</xref>). Pioneering studies by Araque et al. (<xref ref-type="bibr" rid="B12">1998a</xref>,<xref ref-type="bibr" rid="B13">b</xref>) served to later coin the term “tripartite synapse”, which describes how astrocytic processes together with pre- and postsynaptic terminals constitute a functional structure that sustain the activity of neural circuits (Eroglu and Barres, <xref ref-type="bibr" rid="B56">2010</xref>). In this delicate physical and functional interaction, astrocytes sense and respond to neuronal activity by releasing bioactive molecules termed “gliotransmitters” through different pathways, including vesicles, P2X<sub>7</sub>R, volume-regulated anion channels (VRACs), bestrophin-1 Ca<sup>2+</sup>-activated chloride channels, pannexons, hemichannels and transporters (Gundersen et al., <xref ref-type="bibr" rid="B74">2015</xref>). In addition to embracing the synaptic cleft, astrocytes are endowed with specialized terminal processes so called “endfeet”, which ensheath capillaries, intracerebral arterioles and venules; covering almost completely the abluminal vascular surface (Simard et al., <xref ref-type="bibr" rid="B185">2003</xref>). This complex crosstalk with neurons and vascular cells provides astrocytes with an incomparable architectural advantage to facilitate local and long-distance release of gliotransmitters, thereby modulating synaptic transmission and plasticity with potentially significant consequences for memory and behavior (Dallerac and Rouach, <xref ref-type="bibr" rid="B46">2016</xref>).</p>
<p>As already mentioned, retrograde eCB signaling may mediate short-term (Kreitzer and Regehr, <xref ref-type="bibr" rid="B93">2001</xref>; Wilson and Nicoll, <xref ref-type="bibr" rid="B213">2001</xref>) and long-term (Gerdeman et al., <xref ref-type="bibr" rid="B69">2002</xref>; Marsicano et al., <xref ref-type="bibr" rid="B107">2002</xref>) mechanisms of synaptic depression at both excitatory and inhibitory synapses (Navarrete et al., <xref ref-type="bibr" rid="B126">2012</xref>). Surprisingly, although CB<sub>1</sub> receptors are usually coupled to G<sub>i/o</sub> proteins (Piomelli, <xref ref-type="bibr" rid="B149">2003</xref>), the CB<sub>1</sub>-dependent [Ca<sup>2+</sup>]<sub>i</sub> rise in astrocytes depends on the phospholipase C (PLC)-mediated IP<sub>3</sub> production, indicating the involvement of G<sub>q</sub> proteins rather than a “classical” inhibition of adenylate cyclase (Navarrete et al., <xref ref-type="bibr" rid="B126">2012</xref>). Quite remarkably, eCB release from neurons requires astroglial Ca<sup>2+</sup> elevations to stimulate glutamate release from astrocytes, which in turn, increases the frequency of postsynaptic NMDA receptor (NMDAR)-mediated slow inward currents (SIC) in proximal pyramidal neurons (Navarrete et al., <xref ref-type="bibr" rid="B126">2012</xref>). A study from the same group described that [Ca<sup>2+</sup>]<sub>i</sub> rise elicited by astroglial CB<sub>1</sub> receptors lead to heterosynaptic short-term facilitation of synaptic transmission, likely through glutamate released from astrocytes and subsequent activation of presynaptic metabotropic glutamate receptors type-1 (mGluR1; Navarrete and Araque, <xref ref-type="bibr" rid="B125">2010</xref>). These studies reinforce the idea that while eCBs trigger transient synaptic depression at local synapses via presynaptic CB<sub>1</sub> receptors, they also induce transient synaptic potentiation at distant synapses through activation of astrocytic CB<sub>1</sub> receptors.</p>
<p>The involvement of astroglial CB<sub>1</sub> receptors in synaptic transmission also include processes of long-term plasticity. Indeed, stimulation of astroglial CB<sub>1</sub> receptors increases [Ca<sup>2+</sup>]<sub>i</sub> and causes glutamate release from astrocytes, which by activating presynaptic NMDARs trigger spike timing dependent long-term depression (t-LTD; Min and Nevian, <xref ref-type="bibr" rid="B116">2012</xref>). Equivalent mechanisms of t-LTD have been found in the hippocampus, yet in these cases, either D-serine or glutamate seem the gliotransmitters involved in presynaptic or postsynaptic activation of NMDARs, respectively (Han et al., <xref ref-type="bibr" rid="B76">2012</xref>; Andrade-Talavera et al., <xref ref-type="bibr" rid="B9">2016</xref>). Noticeably, astroglial CB<sub>1</sub> receptor-mediated t-LTD is critical for inducing the impairment of working memory <italic>in vivo</italic>, with the latter response being dependent on activation of NR2B-containing NMDARs and endocytosis of AMPARs (Han et al., <xref ref-type="bibr" rid="B76">2012</xref>). Examples of astroglial participation in CB1 receptor-mediated long-term plasticity also include synaptic facilitation. Just a while ago, it was described that eCB-mediated activation of astroglial CB<sub>1</sub> receptors elevates [Ca<sup>2+</sup>]<sub>i</sub> and induces glutamate release that acting on presynaptic mGluR1s evokes long-term potentiation (LTP) when it coincides with the postsynaptic release of NO (Gómez-Gonzalo et al., <xref ref-type="bibr" rid="B72">2015</xref>). Similar events of LTP facilitation have been described in the mouse neocortex with the ATP as major gliotransmitter implicated (Rasooli-Nejad et al., <xref ref-type="bibr" rid="B157">2014</xref>). These studies open up the possibility that eCBs may have opposite and complementary regulatory effects, namely, while their signaling lead to transient or LTD via presynaptic CB<sub>1</sub> receptors in local homoneuronal synapses (Wilson and Nicoll, <xref ref-type="bibr" rid="B213">2001</xref>; Chevaleyre and Castillo, <xref ref-type="bibr" rid="B34">2003</xref>), they transiently (Navarrete and Araque, <xref ref-type="bibr" rid="B125">2010</xref>) or persistently (Gómez-Gonzalo et al., <xref ref-type="bibr" rid="B72">2015</xref>) potentiate synaptic transmission at more distant synapses through activation of astrocytes. It is unclear whether these opposite mechanisms might coexist <italic>in vivo</italic> or whether they occur only in specific physiological or pathophysiological circumstances.</p>
<p>While a lot has been learned about the role of astrocytes on eCB-mediated synaptic plasticity, how exactly gliotransmitters are released from astrocytes is uncertain but it could involve vesicular exocytosis in some cases. Using the light chain of tetanus toxin and Evans blue, an inhibitor of the vesicular glutamate transporter, Min and Nevian (<xref ref-type="bibr" rid="B116">2012</xref>) demonstrated that eCB-mediated t-LTD requires the SNARE-dependent exocytosis of astroglial glutamate. Likewise, other study showed that eCBs trigger release of ATP and D-serine from neocortical astrocytes by SNARE-complex-dependent mechanism, with ATP being crucial for LTP facilitation (Rasooli-Nejad et al., <xref ref-type="bibr" rid="B157">2014</xref>). Although it is well-accepted that [Ca<sup>2+</sup>]<sub>i</sub>-dependent vesicular fusion of either large or small synaptic-like vesicles (Araque et al., <xref ref-type="bibr" rid="B11">2000</xref>; Bezzi et al., <xref ref-type="bibr" rid="B22">2004</xref>; Martineau et al., <xref ref-type="bibr" rid="B108">2008</xref>, <xref ref-type="bibr" rid="B109">2013</xref>; Kang et al., <xref ref-type="bibr" rid="B83">2013</xref>) lead to glutamate and D-serine release from astrocytes, the involvement of alternative non-vesicular pathways in eCB-mediated plasticity deserve more investigation. One alternative mechanism may reside in the opening of hemichannels, either directly as a route for diffusion or indirectly by favoring Ca<sup>2+</sup> entry that subsequently activates other [Ca<sup>2+</sup>]<sub>i</sub>-dependent gliotransmitter release pathways (Montero and Orellana, <xref ref-type="bibr" rid="B121">2015</xref>). Certainly, hemichannels formed by Cx43, the predominant channels of their kind in astrocytes, have already been associated with the release of diverse gliotransmitters such as glutamate (Ye et al., <xref ref-type="bibr" rid="B215">2003</xref>; Orellana et al., <xref ref-type="bibr" rid="B135">2011b</xref>), ATP (Stout et al., <xref ref-type="bibr" rid="B193">2002</xref>; Kang et al., <xref ref-type="bibr" rid="B82">2008</xref>; Chever et al., <xref ref-type="bibr" rid="B36">2014</xref>), D-serine (Meunier et al., <xref ref-type="bibr" rid="B115">2017</xref>), glutathione (Rana and Dringen, <xref ref-type="bibr" rid="B156">2007</xref>) and lactate (Karagiannis et al., <xref ref-type="bibr" rid="B84">2016</xref>). A while ago, it was showed that lowering extracellular Ca<sup>2+</sup> to concentrations that take place during neuronal bursting activity, causes ATP efflux via astroglial Cx43 hemichannels, which subsequently strengths inhibitory transmission by activation of neuronal P2Y<sub>1</sub>R (Torres et al., <xref ref-type="bibr" rid="B200">2012</xref>). The latter study brought to light the idea that gliotransmitter release linked to the physiological opening of astroglial hemichannels may regulate synaptic transmission. This was demonstrated later on by Chever et al. (<xref ref-type="bibr" rid="B36">2014</xref>), who found that constitutive function of astroglial Cx43 hemichannels contributes to ATP release and tuning of basal excitatory synaptic transmission in the hippocampus.</p>
<p>Additionally, when studied in basal conditions, the opening of astroglial Cx43 hemichannels enhances the amplitude of slow oscillations in mitral cells of the olfactory bulb (Roux et al., <xref ref-type="bibr" rid="B163">2015</xref>) and is essential for fear memory consolidation in the basolateral amygdala (BLA), a brain region crucial for anxiety and emotional memory processing (Stehberg et al., <xref ref-type="bibr" rid="B189">2012</xref>). The last-mentioned study revealed that microinjection of the BLA with TAT-L2, a peptide that specifically blocks Cx43 hemichannels, does not affect short-term memory, but fully induces amnesia towards an auditory fear conditioning paradigm (Stehberg et al., <xref ref-type="bibr" rid="B189">2012</xref>). TAT-L2, along with Gap19, are the most predominant pharmacological tools used to inhibit hemichannel function without affecting gap junctional communication (Iyyathurai et al., <xref ref-type="bibr" rid="B81">2013</xref>). TAT-L2 is a cell-permeable mimetic peptide of the so-called L2 cytoplasmic loop region of Cx43, whereas Gap19 is a smaller nonapeptide derived from it (Iyyathurai et al., <xref ref-type="bibr" rid="B81">2013</xref>). Remarkably, the TAT-L2-mediated amnesic response was prevented by co-infusing a mixture of gliotransmitters together with the peptide, including glutamate, D-serine, glycine, lactate, ATP and glutamine. Likewise, Cx43 hemichannels appear to be critical for spatial memory. Using the spontaneous alternation Y maze training, a recent study reported that blockade of astroglial Cx43 hemichannels impairs hippocampal-dependent short-term spatial memory, but not working memory (Walrave et al., <xref ref-type="bibr" rid="B204">2016</xref>). Decisive evidence establishing the involvement of astroglial hemichannels in regulating synaptic transmission came from a recent study of Giaume’s group. They observed that Cx43 hemichannel inhibition and clamping [Ca<sup>2+</sup>]<sub>i</sub> in astrocytes decreases NMDA but not AMPA postsynaptic currents in the prefrontal cortex (Meunier et al., <xref ref-type="bibr" rid="B115">2017</xref>). Furthermore, electrophysiological experiments of high frequency stimulation revealed D-serine release linked to astroglial Cx43 hemichannel opening is crucial for LTP of NMDA or AMPA synaptic currents (Meunier et al., <xref ref-type="bibr" rid="B115">2017</xref>). This study uncover a possible mechanism to explain previous findings showing that exogenous administration of D-serine revert LTP impairment caused by inhibition of [Ca<sup>2+</sup>]<sub>i</sub> oscillations in astrocytes (Henneberger et al., <xref ref-type="bibr" rid="B78">2010</xref>).</p>
<p>Overall, the above studies provide a solid picture about the role of astroglial hemichannels in synaptic transmission and thus their involvement on eCB-mediated neural plasticity could be critical. How hemichannels may contribute to the eCB-dependent synaptic dialog between astrocytes and neurons? Given that postsynaptic eCBs cause the [Ca<sup>2+</sup>]<sub>i</sub>-dependent release of glutamate and D-serine from astrocytes (Navarrete and Araque, <xref ref-type="bibr" rid="B124">2008</xref>, <xref ref-type="bibr" rid="B125">2010</xref>; Andrade-Talavera et al., <xref ref-type="bibr" rid="B9">2016</xref>), one may question whether Cx43 hemichannels are involved in this process. In this line, a recent work has shown that eCBs may activate astrocytic hemichannels under basal conditions. Using two-photon <italic>in vivo</italic> microscopy, Vázquez et al. (<xref ref-type="bibr" rid="B202">2015</xref>) detected an increased basal activity of astroglial Cx43 hemichannels in the cortex of FAAH-null mice, which possess 15-fold augmented endogenous brain levels of AEA (Cravatt et al., <xref ref-type="bibr" rid="B40">2001</xref>). Equivalent results were observed when AEA was directly applied in the mouse cortex (Vázquez et al., <xref ref-type="bibr" rid="B202">2015</xref>), attributing to eCBs the ability of stimulate basal activity of astroglial hemichannels in the normal brain. It is noteworthy that CB<sub>1</sub>-dependent elevation of [Ca<sup>2+</sup>]<sub>i</sub> in astrocytes relies on PLC activation and further IP<sub>3</sub> production (Navarrete and Araque, <xref ref-type="bibr" rid="B124">2008</xref>), the latter being a well-recognized pathway involved in the activation of Cx43 hemichannels (De Bock et al., <xref ref-type="bibr" rid="B47">2012</xref>; Orellana et al., <xref ref-type="bibr" rid="B139">2012a</xref>; Bol et al., <xref ref-type="bibr" rid="B26">2017</xref>), including in astrocytes (Alvarez et al., <xref ref-type="bibr" rid="B6">2016</xref>). Indeed, the opening of Cx43 hemichannels respond to changes in cytoplasmic Ca<sup>2+</sup> according to a bell-shaped “convex-up” pattern, with maximal activity in the 500 nM range and decreasing activities at both higher and lower [Ca<sup>2+</sup>]<sub>i</sub> (De Bock et al., <xref ref-type="bibr" rid="B47">2012</xref>). Dye uptake and single-channel recordings have been used to prove this feature in astrocytes, glioma cells and other cells types (De Vuyst et al., <xref ref-type="bibr" rid="B48">2009</xref>; De Bock et al., <xref ref-type="bibr" rid="B47">2012</xref>; Wang et al., <xref ref-type="bibr" rid="B208">2013b</xref>; Bol et al., <xref ref-type="bibr" rid="B26">2017</xref>; Meunier et al., <xref ref-type="bibr" rid="B115">2017</xref>). This evidence places the hemichannels as possible candidates to mediate directly or indirectly the eCB-dependent release of glutamate, D-serine or ATP from astrocytes, the latter being potentially significant for neuronal synaptic function (Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Possible roles of connexin- and pannexin-based channels in CB-mediated synaptic plasticity through activation of astrocytes. In the hippocampus, the activity-dependent production of eCB triggers a decrease of neurotransmitter release through the stimulation of presynaptic CB<sub>1</sub>Rs in homoneuronal synapses (1). In the cortex and hippocampus, the coincidence of postsynaptic metabotropic glutamate receptor (mGluR) activation during synaptic activity and Ca<sup>2+</sup> influx (not depicted) caused by postsynaptic back-propagating action potentials evoke the release of eCBs (2). The latter stimulates astroglial CB<sub>1</sub> receptors and could elicit the Ca<sup>2+</sup>-dependent release of glutamate or D-serine through Cx43 hemichannels (3), leading to the activation of presynaptic NMDA receptors (NMDARs) and subsequent induction of spike timing dependent long-term depression (t-LTD; Min and Nevian, <xref ref-type="bibr" rid="B116">2012</xref>; Andrade-Talavera et al., <xref ref-type="bibr" rid="B9">2016</xref>). Alternatively, in the hippocampus, astroglial CB<sub>1</sub> receptor activation and rise of cytoplasmic Ca<sup>2+</sup> may cause the Cx43 hemichannel-dependent release of glutamate (4) which, through the stimulation of postsynaptic NMDAR, elicits the internalization of AMPARs and further t-LTD (Han et al., <xref ref-type="bibr" rid="B76">2012</xref>). At the other end, the eCB-mediated increase in cytoplasmic Ca<sup>2+</sup> may trigger the release of glutamate through Cx43 hemichannels (5) that, acting on mGluRs induces lateral potentiation of synaptic transmission at distant synapses (Navarrete and Araque, <xref ref-type="bibr" rid="B125">2010</xref>; Gómez-Gonzalo et al., <xref ref-type="bibr" rid="B72">2015</xref>). The interacting coupling between NMDARs and Pannexin 1 (Panx1) channels could be a possible mechanism to potentiate the above response. Finally, purinergic signaling mediated by ATP released via Panx1 channels (6) along with gap junctional communication (7) among astrocytes could favor the widespread of eCB-mediated intracellular Ca<sup>2+</sup> responses.</p>
</caption>
<graphic xlink:href="fnmol-11-00079-g0003"></graphic>
</fig>
<p>Another angle not mentioned so far is the eventual contribution of connexin/pannexin-dependent widespread of astrocyte Ca<sup>2+</sup> responses in gliotransmission and subsequent CB-mediated potentiation of heterosynaptic plasticity at distant synapses (Navarrete and Araque, <xref ref-type="bibr" rid="B125">2010</xref>; Gómez-Gonzalo et al., <xref ref-type="bibr" rid="B72">2015</xref>). Although ATP seems released through different pathways (Zhang et al., <xref ref-type="bibr" rid="B217">2007</xref>; Kreft et al., <xref ref-type="bibr" rid="B92">2009</xref>), several studies suggests that hemichannels and pannexons are the major contributors to this phenomenon in astrocytes (Stout et al., <xref ref-type="bibr" rid="B193">2002</xref>; Kang et al., <xref ref-type="bibr" rid="B82">2008</xref>; Suadicani et al., <xref ref-type="bibr" rid="B194">2012</xref>). Noteworthy, Panx1 channel-dependent release of ATP relies on protein-protein interactions between P2X<sub>7</sub>Rs and Panx1 (Locovei et al., <xref ref-type="bibr" rid="B97">2007</xref>). In fact, Panx1 co-immunoprecipitates with P2X<sub>7</sub>Rs (Pelegrin and Surprenant, <xref ref-type="bibr" rid="B145">2006</xref>; Silverman et al., <xref ref-type="bibr" rid="B184">2009</xref>), and proline 451 in their C-terminal tails has been involved in this interaction (Iglesias et al., <xref ref-type="bibr" rid="B80">2008</xref>; Sorge et al., <xref ref-type="bibr" rid="B187">2012</xref>). P2YR stimulation also may mediate ATP efflux from astrocytes by activating the PLC/IP<sub>3</sub>/Ca<sup>2+</sup>-dependent opening of hemichannels and pannexons, as has been previously demonstrated for other cell types (Locovei et al., <xref ref-type="bibr" rid="B98">2006</xref>; Orellana et al., <xref ref-type="bibr" rid="B139">2012a</xref>). In addition, because hemichannels are permeable to Ca<sup>2+</sup> (Sánchez et al., <xref ref-type="bibr" rid="B173">2009</xref>; Schalper et al., <xref ref-type="bibr" rid="B177">2010</xref>; Fiori et al., <xref ref-type="bibr" rid="B61">2012</xref>), their dependency on [Ca<sup>2+</sup>]<sub>i</sub> may contribute to perpetuate [Ca<sup>2+</sup>]<sub>i</sub>-induced Ca<sup>2+</sup> entry pathways associated to ATP release. Altogether, these data highlight that ATP signaling via purinergic receptors, hemichannels and pannexons may represent a plausible mechanism for underlying the CB<sub>1</sub>-dependent astroglial modulation of synaptic transmission and plasticity (Figure <xref ref-type="fig" rid="F3">3</xref>). In agreement with this notion, ATP released from eCB-stimulated astrocytes directly activates post-synaptic P2XRs, facilitating LTP due to downregulation of synaptic and extra-synaptic GABA receptors in cortical pyramidal neurons (Rasooli-Nejad et al., <xref ref-type="bibr" rid="B157">2014</xref>). Desensitization of purinergic P2XRs/P2YRs and degradation of extracellular ATP by exonucleases may turn off in part ATP-dependent widespread of Ca<sup>2+</sup> responses in astrocytes (Fields and Burnstock, <xref ref-type="bibr" rid="B60">2006</xref>). Other negative feedback loops may reside in the direct counteracting action of ATP on Panx1 channels (Qiu and Dahl, <xref ref-type="bibr" rid="B154">2009</xref>), as well as the inhibition of Cx43 hemichannels by [Ca<sup>2+</sup>]<sub>i</sub> over 500 nM (Meunier et al., <xref ref-type="bibr" rid="B115">2017</xref>). Future studies will uncover whether opening of hemichannels and pannexons may contribute to astrocyte signaling during eCB-mediated synaptic transmission and plasticity.</p>
<p>In addition to contributing to astroglial-mediated release of gliotransmitters, Panx1 channels may also regulate synaptic communication given its broad expression and functionality in neurons (Thompson, <xref ref-type="bibr" rid="B199">2015</xref>). Precisely, Panx1 is mainly found in the postsynaptic density of excitatory neurons (Zoidl et al., <xref ref-type="bibr" rid="B219">2007</xref>) and couple NMDARs (Weilinger et al., <xref ref-type="bibr" rid="B211">2012</xref>), making it well positioned to participate in eCB-mediated synaptic plasticity. Two independent groups have showed that acute hippocampal slices from adult Panx1 KO mice exhibit a significant increase in synaptic transmission, as measured in input-output curves at the hippocampal Schaffer-collateral CA1 synapse (Prochnow et al., <xref ref-type="bibr" rid="B152">2012</xref>; Ardiles et al., <xref ref-type="bibr" rid="B14">2014</xref>). As either adenosine application or blockade of NMDARs restored normal synaptic transmission (Prochnow et al., <xref ref-type="bibr" rid="B152">2012</xref>), it is possible that loss of Panx1 may trigger extracellular adenosine depletion, thus favoring activation of postsynaptic NMDARs. Supporting this idea, stimulation of adenosine A1 receptors blunt the release of glutamate from pre-synaptic terminals (Dunwiddie and Masino, <xref ref-type="bibr" rid="B55">2001</xref>) and hyperpolarizes post-synaptic neurons via ATP-sensitive K<sup>+</sup> channels (Kawamura et al., <xref ref-type="bibr" rid="B86">2010</xref>). Up to now, it is unclear whether a similar mechanism might account for transient or long-term eCB-mediated synaptic depression in the hippocampus or cortex (Han et al., <xref ref-type="bibr" rid="B76">2012</xref>; Min and Nevian, <xref ref-type="bibr" rid="B116">2012</xref>; Andrade-Talavera et al., <xref ref-type="bibr" rid="B9">2016</xref>).</p>
</sec>
<sec id="s5">
<title>Concluding Remarks and Future Directions</title>
<p>As we noted before, it seems that the outcome of CBs in the functional activity of hemichannels will depend on the physiological status of the brain. Namely, under physiological conditions, eCBs may induce the controlled opening of astrocyte hemichannels and the consequent release of gliotransmitters. This may be particularly relevant for transient or long-lasting mechanisms of synaptic transmission and plasticity evoked by eCBs. At the other end, in the inflamed brain, eCBs may counteract the dysfunctional opening of hemichannels by triggering a large-scale of anti-inflammatory pathways that result in the inhibition of hemichannels and stimulation of astroglial coupling. The exact scenario and cellular cascades by which eCBs lead to this dual opposite regulation of hemichannels remain uncertain. Nevertheless, part of the explanation may rely in that eCBs may have different outcomes depending on which CB receptor they are exerting their actions. Additionally, the altered expression and production of CB receptors and eCBs during pathological conditions, respectively, may trigger different pathways that oppositely regulate the function of hemichannels. Considering the recent evidence linking the activity of GJCs, hemichannels and pannexons with major depression, addiction, autism, epilepsy and schizophrenia (Sarrouilhe et al., <xref ref-type="bibr" rid="B174">2017</xref>), one may question whether the dialog between connexin/pannexin-based channels and the CB system may also impact the pathogenesis and progression of psychiatric disorders. At the other end, given the well-established role of eCB receptors in adult neurogenesis (Prenderville et al., <xref ref-type="bibr" rid="B151">2015</xref>) and because connexin/pannexin function has been implicated in this process (Rozental et al., <xref ref-type="bibr" rid="B166">1998</xref>; Swayne et al., <xref ref-type="bibr" rid="B197">2010</xref>; Liebmann et al., <xref ref-type="bibr" rid="B96">2013</xref>; Salmina et al., <xref ref-type="bibr" rid="B171">2014</xref>; Swayne and Bennett, <xref ref-type="bibr" rid="B196">2016</xref>), it would be interesting to unveil how the interaction between both pathways may impact neural progenitor proliferation, neuronal differentiation, maturation and survival. The mechanisms involved in all these events need to be studied further to better understand their biological implications for developing novel therapies against different brain diseases.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>JAO: conceived and designed the major ideas developed in the manuscript. VCL, CAS, RG-G, EFD, GIG and JAO: reviewed the literature and designed the figures; wrote and edited the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We thank CONICYT, PIA, FONDECYT and Pontificia Universidad Católica de Chile.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) and Programa de Investigación Asociativa (PIA): Grant Anillo de Ciencia y Tecnología ACT1411 (to JAO); Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT): Grant 1160710 (to JAO).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abudara</surname><given-names>V.</given-names></name><name><surname>Roux</surname><given-names>L.</given-names></name><name><surname>Dallérac</surname><given-names>G.</given-names></name><name><surname>Matias</surname><given-names>I.</given-names></name><name><surname>Dulong</surname><given-names>J.</given-names></name><name><surname>Mothet</surname><given-names>J. P.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes</article-title>. <source/>Glia
<volume>63</volume>, <fpage>795</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22785</pub-id><pub-id pub-id-type="pmid">25643695</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamson</surname><given-names>S. E.</given-names></name><name><surname>Leitinger</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of pannexin1 in the induction and resolution of inflammation</article-title>. <source/>FEBS Lett.
<volume>588</volume>, <fpage>1416</fpage>–<lpage>1422</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2014.03.009</pub-id><pub-id pub-id-type="pmid">24642372</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguirre-Rueda</surname><given-names>D.</given-names></name><name><surname>Guerra-Ojeda</surname><given-names>S.</given-names></name><name><surname>Aldasoro</surname><given-names>M.</given-names></name><name><surname>Iradi</surname><given-names>A.</given-names></name><name><surname>Obrador</surname><given-names>E.</given-names></name><name><surname>Mauricio</surname><given-names>M. D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>WIN 55,212–2, agonist of cannabinoid receptors, prevents amyloid β1–42 effects on astrocytes in primary culture</article-title>. <source/>PLoS One
<volume>10</volume>:<fpage>e0122843</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0122843</pub-id><pub-id pub-id-type="pmid">25874692</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>N. J.</given-names></name><name><surname>Eroglu</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Cell biology of astrocyte-synapse interactions</article-title>. <source/>Neuron
<volume>96</volume>, <fpage>697</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.056</pub-id><pub-id pub-id-type="pmid">29096081</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almad</surname><given-names>A. A.</given-names></name><name><surname>Doreswamy</surname><given-names>A.</given-names></name><name><surname>Gross</surname><given-names>S. K.</given-names></name><name><surname>Richard</surname><given-names>J. P.</given-names></name><name><surname>Huo</surname><given-names>Y.</given-names></name><name><surname>Haughey</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis</article-title>. <source/>Glia
<volume>64</volume>, <fpage>1154</fpage>–<lpage>1169</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22989</pub-id><pub-id pub-id-type="pmid">27083773</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>A.</given-names></name><name><surname>Lagos-Cabré</surname><given-names>R.</given-names></name><name><surname>Kong</surname><given-names>M.</given-names></name><name><surname>Cárdenas</surname><given-names>A.</given-names></name><name><surname>Burgos-Bravo</surname><given-names>F.</given-names></name><name><surname>Schneider</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Integrin-mediated transactivation of P2X7R via hemichannel-dependent ATP release stimulates astrocyte migration</article-title>. <source/>Biochim. Biophys. Acta
<volume>1863</volume>, <fpage>2175</fpage>–<lpage>2188</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.05.018</pub-id><pub-id pub-id-type="pmid">27235833</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname><given-names>C.</given-names></name><name><surname>Gassmann</surname><given-names>O.</given-names></name><name><surname>Pranskevich</surname><given-names>J. N.</given-names></name><name><surname>Boassa</surname><given-names>D.</given-names></name><name><surname>Smock</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Pannexin1 and Pannexin2 channels show quaternary similarities to connexons and different oligomerization numbers from each other</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>, <fpage>24420</fpage>–<lpage>24431</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.115444</pub-id><pub-id pub-id-type="pmid">20516070</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>C. M.</given-names></name><name><surname>Bergher</surname><given-names>J. P.</given-names></name><name><surname>Swanson</surname><given-names>R. A.</given-names></name></person-group> (<year>2004</year>). <article-title>ATP-induced ATP release from astrocytes</article-title>. <source/>J. Neurochem.
<volume>88</volume>, <fpage>246</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02204.x</pub-id><pub-id pub-id-type="pmid">14675168</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Talavera</surname><given-names>Y.</given-names></name><name><surname>Duque-Feria</surname><given-names>P.</given-names></name><name><surname>Paulsen</surname><given-names>O.</given-names></name><name><surname>Rodríguez-Moreno</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Presynaptic spike timing-dependent long-term depression in the mouse hippocampus</article-title>. <source/>Cereb. Cortex
<volume>26</volume>, <fpage>3637</fpage>–<lpage>3654</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhw172</pub-id><pub-id pub-id-type="pmid">27282393</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname><given-names>A.</given-names></name><name><surname>Carmignoto</surname><given-names>G.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name><name><surname>Oliet</surname><given-names>S. H.</given-names></name><name><surname>Robitaille</surname><given-names>R.</given-names></name><name><surname>Volterra</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Gliotransmitters travel in time and space</article-title>. <source/>Neuron
<volume>81</volume>, <fpage>728</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.007</pub-id><pub-id pub-id-type="pmid">24559669</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Doyle</surname><given-names>R. T.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name></person-group> (<year>2000</year>). <article-title>SNARE protein-dependent glutamate release from astrocytes</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>666</fpage>–<lpage>673</lpage>. <pub-id pub-id-type="pmid">10632596</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname><given-names>A.</given-names></name><name><surname>Parpura</surname><given-names>V.</given-names></name><name><surname>Sanzgiri</surname><given-names>R. P.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name></person-group> (<year>1998a</year>). <article-title>Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons</article-title>. <source/>Eur. J. Neurosci.
<volume>10</volume>, <fpage>2129</fpage>–<lpage>2142</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.1998.00221.x</pub-id><pub-id pub-id-type="pmid">9753099</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname><given-names>A.</given-names></name><name><surname>Sanzgiri</surname><given-names>R. P.</given-names></name><name><surname>Parpura</surname><given-names>V.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name></person-group> (<year>1998b</year>). <article-title>Calcium elevation in astrocytes causes an NMDA receptor-dependent increase in the frequency of miniature synaptic currents in cultured hippocampal neurons</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>6822</fpage>–<lpage>6829</lpage>. <pub-id pub-id-type="pmid">9712653</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardiles</surname><given-names>A. O.</given-names></name><name><surname>Flores-Muñoz</surname><given-names>C.</given-names></name><name><surname>Toro-Ayala</surname><given-names>G.</given-names></name><name><surname>Cárdenas</surname><given-names>A. M.</given-names></name><name><surname>Palacios</surname><given-names>A. G.</given-names></name><name><surname>Muñoz</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Pannexin 1 regulates bidirectional hippocampal synaptic plasticity in adult mice</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<fpage>326</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00326</pub-id><pub-id pub-id-type="pmid">25360084</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avendaño</surname><given-names>B. C.</given-names></name><name><surname>Montero</surname><given-names>T. D.</given-names></name><name><surname>Chávez</surname><given-names>C. E.</given-names></name><name><surname>von Bernhardi</surname><given-names>R.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Prenatal exposure to inflammatory conditions increases Cx43 and Panx1 unopposed channel opening and activation of astrocytes in the offspring effect on neuronal survival</article-title>. <source/>Glia
<volume>63</volume>, <fpage>2058</fpage>–<lpage>2072</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22877</pub-id><pub-id pub-id-type="pmid">26096155</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battista</surname><given-names>N.</given-names></name><name><surname>Fezza</surname><given-names>F.</given-names></name><name><surname>Finazzi-Agrò</surname><given-names>A.</given-names></name><name><surname>Maccarrone</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>The endocannabinoid system in neurodegeneration</article-title>. <source/>Ital. J. Biochem.
<volume>55</volume>, <fpage>283</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="pmid">17274532</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becher</surname><given-names>B.</given-names></name><name><surname>Spath</surname><given-names>S.</given-names></name><name><surname>Goverman</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Cytokine networks in neuroinflammation</article-title>. <source/>Nat. Rev. Immunol.
<volume>17</volume>, <fpage>49</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.123</pub-id><pub-id pub-id-type="pmid">27916979</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>D. L.</given-names></name><name><surname>Phillips</surname><given-names>A. R.</given-names></name><name><surname>Duft</surname><given-names>B. J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Translating connexin biology into therapeutics</article-title>. <source/>Semin. Cell Dev. Biol.
<volume>50</volume>, <fpage>49</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2015.12.009</pub-id><pub-id pub-id-type="pmid">26688335</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benito</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>W. K.</given-names></name><name><surname>Chavarria</surname><given-names>I.</given-names></name><name><surname>Hillard</surname><given-names>C. J.</given-names></name><name><surname>Mackie</surname><given-names>K.</given-names></name><name><surname>Tolón</surname><given-names>R. M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>2530</fpage>–<lpage>2536</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3923-04.2005</pub-id><pub-id pub-id-type="pmid">15758162</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benito</surname><given-names>C.</given-names></name><name><surname>Romero</surname><given-names>J. P.</given-names></name><name><surname>Tolón</surname><given-names>R. M.</given-names></name><name><surname>Clemente</surname><given-names>D.</given-names></name><name><surname>Docagne</surname><given-names>F.</given-names></name><name><surname>Hillard</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>2396</fpage>–<lpage>2402</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4814-06.2007</pub-id><pub-id pub-id-type="pmid">17329437</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>J. W.</given-names></name><name><surname>Carvallo</surname><given-names>L.</given-names></name><name><surname>Buckner</surname><given-names>C. M.</given-names></name><name><surname>Luers</surname><given-names>A.</given-names></name><name><surname>Prevedel</surname><given-names>L.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS</article-title>. <source/>J. Neuroinflammation
<volume>13</volume>:<fpage>54</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-016-0510-1</pub-id><pub-id pub-id-type="pmid">26934876</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezzi</surname><given-names>P.</given-names></name><name><surname>Gundersen</surname><given-names>V.</given-names></name><name><surname>Galbete</surname><given-names>J. L.</given-names></name><name><surname>Seifert</surname><given-names>G.</given-names></name><name><surname>Steinhäuser</surname><given-names>C.</given-names></name><name><surname>Pilati</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate</article-title>. <source/>Nat. Neurosci.
<volume>7</volume>, <fpage>613</fpage>–<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1038/nn1246</pub-id><pub-id pub-id-type="pmid">15156145</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>P.</given-names></name><name><surname>Mishra</surname><given-names>P.</given-names></name><name><surname>Bose</surname><given-names>D.</given-names></name><name><surname>Durgbanshi</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Cannabis: a neurological remedy or a drug of abuse in india</article-title>. <source/>CNS Neurol. Disord. Drug Targets
<volume>16</volume>, <fpage>576</fpage>–<lpage>584</lpage>. <pub-id pub-id-type="doi">10.2174/1871527316666170424115008</pub-id><pub-id pub-id-type="pmid">28440191</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomfield</surname><given-names>S. A.</given-names></name><name><surname>Volgyi</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>The diverse functional roles and regulation of neuronal gap junctions in the retina</article-title>. <source/>Nat. Rev. Neurosci.
<volume>10</volume>, <fpage>495</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2636</pub-id><pub-id pub-id-type="pmid">19491906</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohlen</surname><given-names>C. J.</given-names></name><name><surname>Bennett</surname><given-names>F. C.</given-names></name><name><surname>Tucker</surname><given-names>A. F.</given-names></name><name><surname>Collins</surname><given-names>H. Y.</given-names></name><name><surname>Mulinyawe</surname><given-names>S. B.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures</article-title>. <source/>Neuron
<volume>94</volume>, <fpage>759.e8</fpage>–<lpage>773.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.043</pub-id><pub-id pub-id-type="pmid">28521131</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bol</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Wacquier</surname><given-names>B.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>Gadicherla</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries</article-title>. <source/>Cardiovasc. Res.
<volume>113</volume>, <fpage>195</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvw215</pub-id><pub-id pub-id-type="pmid">27677282</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>S. R.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name></person-group> (<year>2014</year>). <article-title>The pannexins: past and present</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>58</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00058</pub-id><pub-id pub-id-type="pmid">24600404</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouaboula</surname><given-names>M.</given-names></name><name><surname>Bourrié</surname><given-names>B.</given-names></name><name><surname>Rinaldi-Carmona</surname><given-names>M.</given-names></name><name><surname>Shire</surname><given-names>D.</given-names></name><name><surname>Le Fur</surname><given-names>G.</given-names></name><name><surname>Casellas</surname><given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells</article-title>. <source/>J. Biol. Chem.
<volume>270</volume>, <fpage>13973</fpage>–<lpage>13980</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.23.13973</pub-id><pub-id pub-id-type="pmid">7775459</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruzzone</surname><given-names>R.</given-names></name><name><surname>Hormuzdi</surname><given-names>S. G.</given-names></name><name><surname>Barbe</surname><given-names>M. T.</given-names></name><name><surname>Herb</surname><given-names>A.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Pannexins, a family of gap junction proteins expressed in brain</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>100</volume>, <fpage>13644</fpage>–<lpage>13649</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2233464100</pub-id><pub-id pub-id-type="pmid">14597722</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>N. E.</given-names></name><name><surname>McCoy</surname><given-names>K. L.</given-names></name><name><surname>Mezey</surname><given-names>E.</given-names></name><name><surname>Bonner</surname><given-names>T.</given-names></name><name><surname>Zimmer</surname><given-names>A.</given-names></name><name><surname>Felder</surname><given-names>C. C.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB<sub>2</sub> receptor</article-title>. <source/>Eur. J. Pharmacol.
<volume>396</volume>, <fpage>141</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-2999(00)00211-9</pub-id><pub-id pub-id-type="pmid">10822068</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlisle</surname><given-names>S. J.</given-names></name><name><surname>Marciano-Cabral</surname><given-names>F.</given-names></name><name><surname>Staab</surname><given-names>A.</given-names></name><name><surname>Ludwick</surname><given-names>C.</given-names></name><name><surname>Cabral</surname><given-names>G. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation</article-title>. <source/>Int. Immunopharmacol.
<volume>2</volume>, <fpage>69</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/s1567-5769(01)00147-3</pub-id><pub-id pub-id-type="pmid">11789671</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>P. E.</given-names></name><name><surname>Younts</surname><given-names>T. J.</given-names></name><name><surname>Chávez</surname><given-names>A. E.</given-names></name><name><surname>Hashimotodani</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Endocannabinoid signaling and synaptic function</article-title>. <source/>Neuron
<volume>76</volume>, <fpage>70</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.020</pub-id><pub-id pub-id-type="pmid">23040807</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>Z.</given-names></name><name><surname>Zeng</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Heterosynaptic long-term depression mediated by ATP released from astrocytes</article-title>. <source/>Glia
<volume>61</volume>, <fpage>178</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22425</pub-id><pub-id pub-id-type="pmid">23044720</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevaleyre</surname><given-names>V.</given-names></name><name><surname>Castillo</surname><given-names>P. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability</article-title>. <source/>Neuron
<volume>38</volume>, <fpage>461</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00235-6</pub-id><pub-id pub-id-type="pmid">12741992</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevaleyre</surname><given-names>V.</given-names></name><name><surname>Heifets</surname><given-names>B. D.</given-names></name><name><surname>Kaeser</surname><given-names>P. S.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name><name><surname>Castillo</surname><given-names>P. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1α</article-title>. <source/>Neuron
<volume>54</volume>, <fpage>801</fpage>–<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.05.020</pub-id><pub-id pub-id-type="pmid">17553427</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chever</surname><given-names>O.</given-names></name><name><surname>Lee</surname><given-names>C. Y.</given-names></name><name><surname>Rouach</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>11228</fpage>–<lpage>11232</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0015-14.2014</pub-id><pub-id pub-id-type="pmid">25143604</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childers</surname><given-names>S. R.</given-names></name><name><surname>Deadwyler</surname><given-names>S. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Role of cyclic AMP in the actions of cannabinoid receptors</article-title>. <source/>Biochem. Pharmacol.
<volume>52</volume>, <fpage>819</fpage>–<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(96)00419-4</pub-id><pub-id pub-id-type="pmid">8781498</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codeluppi</surname><given-names>S.</given-names></name><name><surname>Gregory</surname><given-names>E. N.</given-names></name><name><surname>Kjell</surname><given-names>J.</given-names></name><name><surname>Wigerblad</surname><given-names>G.</given-names></name><name><surname>Olson</surname><given-names>L.</given-names></name><name><surname>Svensson</surname><given-names>C. I.</given-names></name></person-group> (<year>2011</year>). <article-title>Influence of rat substrain and growth conditions on the characteristics of primary cultures of adult rat spinal cord astrocytes</article-title>. <source/>J. Neurosci. Methods
<volume>197</volume>, <fpage>118</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2011.02.011</pub-id><pub-id pub-id-type="pmid">21345349</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corcos</surname><given-names>M.</given-names></name><name><surname>Phan</surname><given-names>O.</given-names></name><name><surname>Nezelof</surname><given-names>S.</given-names></name><name><surname>Jeammet</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>[Psychopathology of the cannabis user teenager]</article-title>. <source/>Rev. Prat.
<volume>55</volume>, <fpage>35</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="pmid">15801395</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cravatt</surname><given-names>B. F.</given-names></name><name><surname>Demarest</surname><given-names>K.</given-names></name><name><surname>Patricelli</surname><given-names>M. P.</given-names></name><name><surname>Bracey</surname><given-names>M. H.</given-names></name><name><surname>Giang</surname><given-names>D. K.</given-names></name><name><surname>Martin</surname><given-names>B. R.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>98</volume>, <fpage>9371</fpage>–<lpage>9376</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.161191698</pub-id><pub-id pub-id-type="pmid">11470906</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cravatt</surname><given-names>B. F.</given-names></name><name><surname>Giang</surname><given-names>D. K.</given-names></name><name><surname>Mayfield</surname><given-names>S. P.</given-names></name><name><surname>Boger</surname><given-names>D. L.</given-names></name><name><surname>Lerner</surname><given-names>R. A.</given-names></name><name><surname>Gilula</surname><given-names>N. B.</given-names></name></person-group> (<year>1996</year>). <article-title>Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</article-title>. <source/>Nature
<volume>384</volume>, <fpage>83</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1038/384083a0</pub-id><pub-id pub-id-type="pmid">8900284</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crespo Yanguas</surname><given-names>S.</given-names></name><name><surname>Willebrords</surname><given-names>J.</given-names></name><name><surname>Johnstone</surname><given-names>S. R.</given-names></name><name><surname>Maes</surname><given-names>M.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Pannexin1 as mediator of inflammation and cell death</article-title>. <source/>Biochim. Biophys. Acta
<volume>1864</volume>, <fpage>51</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.10.006</pub-id><pub-id pub-id-type="pmid">27741412</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>N. M.</given-names></name><name><surname>Griffin</surname><given-names>B. D.</given-names></name><name><surname>O’toole</surname><given-names>D.</given-names></name><name><surname>Brady</surname><given-names>K. J.</given-names></name><name><surname>Fitzgerald</surname><given-names>S. N.</given-names></name><name><surname>Moynagh</surname><given-names>P. N.</given-names></name></person-group> (<year>2005</year>). <article-title>The synthetic cannabinoid R(+)WIN 55,212–2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner</article-title>. <source/>J. Biol. Chem.
<volume>280</volume>, <fpage>35797</fpage>–<lpage>35806</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M507959200</pub-id><pub-id pub-id-type="pmid">16105834</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>ATP release through pannexon channels</article-title>. <source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
<volume>370</volume>:<fpage>20140191</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2014.0191</pub-id><pub-id pub-id-type="pmid">26009770</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>G.</given-names></name><name><surname>Keane</surname><given-names>R. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Pannexin: from discovery to bedside in 11±4 years?</article-title>
<source/>Brain Res.
<volume>1487</volume>, <fpage>150</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.04.058</pub-id><pub-id pub-id-type="pmid">22771709</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallerac</surname><given-names>G.</given-names></name><name><surname>Rouach</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Astrocytes as new targets to improve cognitive functions</article-title>. <source/>Prog. Neurobiol.
<volume>144</volume>, <fpage>48</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2016.01.003</pub-id><pub-id pub-id-type="pmid">26969413</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Bol</surname><given-names>M.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>Ponsaerts</surname><given-names>R.</given-names></name><name><surname>Bultynck</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Connexin 43 hemichannels contribute to cytoplasmic Ca<sup>2+</sup> oscillations by providing a bimodal Ca<sup>2+</sup>-dependent Ca<sup>2+</sup> entry pathway</article-title>. <source/>J. Biol. Chem.
<volume>287</volume>, <fpage>12250</fpage>–<lpage>12266</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.299610</pub-id><pub-id pub-id-type="pmid">22351781</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vuyst</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Vinken</surname><given-names>M.</given-names></name><name><surname>Van Moorhem</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Ca<sup>2+</sup> regulation of connexin 43 hemichannels in C6 glioma and glial cells</article-title>. <source/>Cell Calcium
<volume>46</volume>, <fpage>176</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2009.07.002</pub-id><pub-id pub-id-type="pmid">19656565</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Bultynck</surname><given-names>G.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Connexin and pannexin signaling pathways, an architectural blueprint for CNS physiology and pathology?</article-title>
<source/>Cell. Mol. Life Sci.
<volume>72</volume>, <fpage>2823</fpage>–<lpage>2851</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-015-1962-7</pub-id><pub-id pub-id-type="pmid">26118660</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devane</surname><given-names>W. A.</given-names></name><name><surname>Breuer</surname><given-names>A.</given-names></name><name><surname>Sheskin</surname><given-names>T.</given-names></name><name><surname>Järbe</surname><given-names>T. U.</given-names></name><name><surname>Eisen</surname><given-names>M. S.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name></person-group> (<year>1992a</year>). <article-title>A novel probe for the cannabinoid receptor</article-title>. <source/>J. Med. Chem.
<volume>35</volume>, <fpage>2065</fpage>–<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1021/jm00089a018</pub-id><pub-id pub-id-type="pmid">1317925</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devane</surname><given-names>W. A.</given-names></name><name><surname>Hanus</surname><given-names>L.</given-names></name><name><surname>Breuer</surname><given-names>A.</given-names></name><name><surname>Pertwee</surname><given-names>R. G.</given-names></name><name><surname>Stevenson</surname><given-names>L. A.</given-names></name><name><surname>Griffin</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1992b</year>). <article-title>Isolation and structure of a brain constituent that binds to the cannabinoid receptor</article-title>. <source/>Science
<volume>258</volume>, <fpage>1946</fpage>–<lpage>1949</lpage>. <pub-id pub-id-type="doi">10.1126/science.1470919</pub-id><pub-id pub-id-type="pmid">1470919</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Stella</surname><given-names>N.</given-names></name><name><surname>Zimmer</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Endocannabinoid signalling and the deteriorating brain</article-title>. <source/>Nat. Rev. Neurosci.
<volume>16</volume>, <fpage>30</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3876</pub-id><pub-id pub-id-type="pmid">25524120</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>T. P.</given-names></name><name><surname>Freund</surname><given-names>T. F.</given-names></name><name><surname>Piomelli</surname><given-names>D.</given-names></name></person-group> (<year>2002</year>). <article-title>A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation</article-title>. <source/>Chem. Phys. Lipids
<volume>121</volume>, <fpage>149</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/s0009-3084(02)00150-0</pub-id><pub-id pub-id-type="pmid">12505697</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domercq</surname><given-names>M.</given-names></name><name><surname>Perez-Samartin</surname><given-names>A.</given-names></name><name><surname>Aparicio</surname><given-names>D.</given-names></name><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Pampliega</surname><given-names>O.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>P2X7 receptors mediate ischemic damage to oligodendrocytes</article-title>. <source/>Glia
<volume>58</volume>, <fpage>730</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20958</pub-id><pub-id pub-id-type="pmid">20029962</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunwiddie</surname><given-names>T. V.</given-names></name><name><surname>Masino</surname><given-names>S. A.</given-names></name></person-group> (<year>2001</year>). <article-title>The role and regulation of adenosine in the central nervous system</article-title>. <source/>Annu. Rev. Neurosci.
<volume>24</volume>, <fpage>31</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.24.1.31</pub-id><pub-id pub-id-type="pmid">11283304</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eroglu</surname><given-names>C.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Regulation of synaptic connectivity by glia</article-title>. <source/>Nature
<volume>468</volume>, <fpage>223</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1038/nature09612</pub-id><pub-id pub-id-type="pmid">21068831</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esseltine</surname><given-names>J. L.</given-names></name><name><surname>Laird</surname><given-names>D. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Next-generation connexin and pannexin cell biology</article-title>. <source/>Trends Cell Biol.
<volume>26</volume>, <fpage>944</fpage>–<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2016.06.003</pub-id><pub-id pub-id-type="pmid">27339936</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facchinetti</surname><given-names>F.</given-names></name><name><surname>Del Giudice</surname><given-names>E.</given-names></name><name><surname>Furegato</surname><given-names>S.</given-names></name><name><surname>Passarotto</surname><given-names>M.</given-names></name><name><surname>Leon</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide</article-title>. <source/>Glia
<volume>41</volume>, <fpage>161</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10177</pub-id><pub-id pub-id-type="pmid">12509806</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-Trapero</surname><given-names>M.</given-names></name><name><surname>Espejo-Porras</surname><given-names>F.</given-names></name><name><surname>Rodríguez-Cueto</surname><given-names>C.</given-names></name><name><surname>Coates</surname><given-names>J. R.</given-names></name><name><surname>Pérez-Díaz</surname><given-names>C.</given-names></name><name><surname>de Lago</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis</article-title>. <source/>Dis. Model. Mech.
<volume>10</volume>, <fpage>551</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.028373</pub-id><pub-id pub-id-type="pmid">28069688</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>R. D.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Purinergic signalling in neuron-glia interactions</article-title>. <source/>Nat. Rev. Neurosci.
<volume>7</volume>, <fpage>423</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1928</pub-id><pub-id pub-id-type="pmid">16715052</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiori</surname><given-names>M. C.</given-names></name><name><surname>Figueroa</surname><given-names>V.</given-names></name><name><surname>Zoghbi</surname><given-names>M. E.</given-names></name><name><surname>Saéz</surname><given-names>J. C.</given-names></name><name><surname>Reuss</surname><given-names>L.</given-names></name><name><surname>Altenberg</surname><given-names>G. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Permeation of calcium through purified connexin 26 hemichannels</article-title>. <source/>J. Biol. Chem.
<volume>287</volume>, <fpage>40826</fpage>–<lpage>40834</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.383281</pub-id><pub-id pub-id-type="pmid">23048025</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Calvo</surname><given-names>C. F.</given-names></name><name><surname>Amigou</surname><given-names>E.</given-names></name><name><surname>Kozoriz</surname><given-names>M. G.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective</article-title>. <source/>Mol. Cell. Neurosci.
<volume>45</volume>, <fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.05.007</pub-id><pub-id pub-id-type="pmid">20684043</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Cohen-Salmon</surname><given-names>M.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Amigou</surname><given-names>E.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments</article-title>. <source/>J. Neurochem.
<volume>111</volume>, <fpage>1383</fpage>–<lpage>1397</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06407.x</pub-id><pub-id pub-id-type="pmid">20050288</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaete</surname><given-names>P. S.</given-names></name><name><surname>Lillo</surname><given-names>M. A.</given-names></name><name><surname>Figueroa</surname><given-names>X. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Functional role of connexins and pannexins in the interaction between vascular and nervous system</article-title>. <source/>J. Cell. Physiol.
<volume>229</volume>, <fpage>1336</fpage>–<lpage>1345</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24563</pub-id><pub-id pub-id-type="pmid">24446239</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajardo-Gómez</surname><given-names>R.</given-names></name><name><surname>Labra</surname><given-names>V. C.</given-names></name><name><surname>Maturana</surname><given-names>C. J.</given-names></name><name><surname>Shoji</surname><given-names>K. F.</given-names></name><name><surname>Santibañez</surname><given-names>C. A.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: a neuroprotective mechanism</article-title>. <source/>Glia
<volume>65</volume>, <fpage>122</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23080</pub-id><pub-id pub-id-type="pmid">27757991</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galiègue</surname><given-names>S.</given-names></name><name><surname>Mary</surname><given-names>S.</given-names></name><name><surname>Marchand</surname><given-names>J.</given-names></name><name><surname>Dussossoy</surname><given-names>D.</given-names></name><name><surname>Carrière</surname><given-names>D.</given-names></name><name><surname>Carayon</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations</article-title>. <source/>Eur. J. Biochem.
<volume>232</volume>, <fpage>54</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20780.x</pub-id><pub-id pub-id-type="pmid">7556170</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaoni</surname><given-names>Y.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name></person-group> (<year>1964</year>). <article-title>Isolation, structure, and partial synthesis of an active constituent of hashish</article-title>. <source/>J. Am. Chem. Soc.
<volume>86</volume>, <fpage>1646</fpage>–<lpage>1647</lpage>. <pub-id pub-id-type="doi">10.1021/ja01062a046</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garre</surname><given-names>J. M.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Bukauskas</surname><given-names>F. F.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name></person-group> (<year>2016</year>). <article-title>FGF-1 triggers pannexin-1 hemichannel opening in spinal astrocytes of rodents and promotes inflammatory responses in acute spinal cord slices</article-title>. <source/>J. Neurosci.
<volume>36</volume>, <fpage>4785</fpage>–<lpage>4801</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4195-15.2016</pub-id><pub-id pub-id-type="pmid">27122036</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdeman</surname><given-names>G. L.</given-names></name><name><surname>Ronesi</surname><given-names>J.</given-names></name><name><surname>Lovinger</surname><given-names>D. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Postsynaptic endocannabinoid release is critical to long-term depression in the striatum</article-title>. <source/>Nat. Neurosci.
<volume>5</volume>, <fpage>446</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1038/nn832</pub-id><pub-id pub-id-type="pmid">11976704</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giaume</surname><given-names>C.</given-names></name><name><surname>Leybaert</surname><given-names>L.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Connexin and pannexin hemichannels in brain glial cells: properties, pharmacology, and roles</article-title>. <source/>Front. Pharmacol.
<volume>4</volume>:<fpage>88</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2013.00088</pub-id><pub-id pub-id-type="pmid">23882216</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giaume</surname><given-names>C.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>Song</surname><given-names>W.</given-names></name><name><surname>Leybaert</surname><given-names>L.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Connexins and pannexins in Alzheimer’s disease</article-title>. <source/>Neurosci. Lett. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.neulet.2017.09.006</pub-id><pub-id pub-id-type="pmid">28893592</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Gonzalo</surname><given-names>M.</given-names></name><name><surname>Navarrete</surname><given-names>M.</given-names></name><name><surname>Perea</surname><given-names>G.</given-names></name><name><surname>Covelo</surname><given-names>A.</given-names></name><name><surname>Martín-Fernández</surname><given-names>M.</given-names></name><name><surname>Shigemoto</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission</article-title>. <source/>Cereb. Cortex
<volume>25</volume>, <fpage>3699</fpage>–<lpage>3712</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhu231</pub-id><pub-id pub-id-type="pmid">25260706</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>J. P.</given-names></name><name><surname>Onaivi</surname><given-names>E. S.</given-names></name><name><surname>Ishiguro</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Q. R.</given-names></name><name><surname>Tagliaferro</surname><given-names>P. A.</given-names></name><name><surname>Brusco</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Cannabinoid CB2 receptors: immunohistochemical localization in rat brain</article-title>. <source/>Brain Res.
<volume>1071</volume>, <fpage>10</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.11.035</pub-id><pub-id pub-id-type="pmid">16472786</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundersen</surname><given-names>V.</given-names></name><name><surname>Storm-Mathisen</surname><given-names>J.</given-names></name><name><surname>Bergersen</surname><given-names>L. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroglial transmission</article-title>. <source/>Physiol. Rev.
<volume>95</volume>, <fpage>695</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00024.2014</pub-id><pub-id pub-id-type="pmid">26084688</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guthrie</surname><given-names>P. B.</given-names></name><name><surname>Knappenberger</surname><given-names>J.</given-names></name><name><surname>Segal</surname><given-names>M.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Charles</surname><given-names>A. C.</given-names></name><name><surname>Kater</surname><given-names>S. B.</given-names></name></person-group> (<year>1999</year>). <article-title>ATP released from astrocytes mediates glial calcium waves</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>520</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="pmid">9880572</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Kesner</surname><given-names>P.</given-names></name><name><surname>Metna-Laurent</surname><given-names>M.</given-names></name><name><surname>Duan</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Georges</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD</article-title>. <source/>Cell
<volume>148</volume>, <fpage>1039</fpage>–<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.01.037</pub-id><pub-id pub-id-type="pmid">22385967</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanus</surname><given-names>L.</given-names></name><name><surname>Abu-Lafi</surname><given-names>S.</given-names></name><name><surname>Fride</surname><given-names>E.</given-names></name><name><surname>Breuer</surname><given-names>A.</given-names></name><name><surname>Vogel</surname><given-names>Z.</given-names></name><name><surname>Shalev</surname><given-names>D. E.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>98</volume>, <fpage>3662</fpage>–<lpage>3665</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.061029898</pub-id><pub-id pub-id-type="pmid">11259648</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henneberger</surname><given-names>C.</given-names></name><name><surname>Papouin</surname><given-names>T.</given-names></name><name><surname>Oliet</surname><given-names>S. H.</given-names></name><name><surname>Rusakov</surname><given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Long-term potentiation depends on release of D-serine from astrocytes</article-title>. <source/>Nature
<volume>463</volume>, <fpage>232</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1038/nature08673</pub-id><pub-id pub-id-type="pmid">20075918</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadecola</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease</article-title>. <source/>Neuron
<volume>96</volume>, <fpage>17</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.030</pub-id><pub-id pub-id-type="pmid">28957666</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias</surname><given-names>R.</given-names></name><name><surname>Locovei</surname><given-names>S.</given-names></name><name><surname>Roque</surname><given-names>A.</given-names></name><name><surname>Alberto</surname><given-names>A. P.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name><name><surname>Spray</surname><given-names>D. C.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>P2X7 receptor-Pannexin1 complex: pharmacology and signaling</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>295</volume>, <fpage>C752</fpage>–<lpage>C760</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00228.2008</pub-id><pub-id pub-id-type="pmid">18596211</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyyathurai</surname><given-names>J.</given-names></name><name><surname>D’Hondt</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Himpens</surname><given-names>B.</given-names></name><name><surname>Retamal</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Peptides and peptide-derived molecules targeting the intracellular domains of Cx43: gap junctions versus hemichannels</article-title>. <source/>Neuropharmacology
<volume>75</volume>, <fpage>491</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.050</pub-id><pub-id pub-id-type="pmid">23664811</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>N.</given-names></name><name><surname>Lovatt</surname><given-names>D.</given-names></name><name><surname>Torres</surname><given-names>A.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Connexin 43 hemichannels are permeable to ATP</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>4702</fpage>–<lpage>4711</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5048-07.2008</pub-id><pub-id pub-id-type="pmid">18448647</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>N.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Stanton</surname><given-names>P. K.</given-names></name><name><surname>Guilarte</surname><given-names>T. R.</given-names></name><name><surname>Kang</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Astrocytes release D-serine by a large vesicle</article-title>. <source/>Neuroscience
<volume>240</volume>, <fpage>243</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.02.029</pub-id><pub-id pub-id-type="pmid">23485803</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagiannis</surname><given-names>A.</given-names></name><name><surname>Sylantyev</surname><given-names>S.</given-names></name><name><surname>Hadjihambi</surname><given-names>A.</given-names></name><name><surname>Hosford</surname><given-names>P. S.</given-names></name><name><surname>Kasparov</surname><given-names>S.</given-names></name><name><surname>Gourine</surname><given-names>A. V.</given-names></name></person-group> (<year>2016</year>). <article-title>Hemichannel-mediated release of lactate</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>36</volume>, <fpage>1202</fpage>–<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X15611912</pub-id><pub-id pub-id-type="pmid">26661210</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpuk</surname><given-names>N.</given-names></name><name><surname>Burkovetskaya</surname><given-names>M.</given-names></name><name><surname>Fritz</surname><given-names>T.</given-names></name><name><surname>Angle</surname><given-names>A.</given-names></name><name><surname>Kielian</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>414</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5247-10.2011</pub-id><pub-id pub-id-type="pmid">21228152</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>M.</given-names></name><name><surname>Ruskin</surname><given-names>D. N.</given-names></name><name><surname>Masino</surname><given-names>S. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors and KATP channels</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>3886</fpage>–<lpage>3895</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0055-10.2010</pub-id><pub-id pub-id-type="pmid">20237259</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendall</surname><given-names>D. A.</given-names></name><name><surname>Yudowski</surname><given-names>G. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Cannabinoid receptors in the central nervous system: their signaling and roles in disease</article-title>. <source/>Front. Cell. Neurosci.
<volume>10</volume>:<fpage>294</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00294</pub-id><pub-id pub-id-type="pmid">28101004</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettenmann</surname><given-names>H.</given-names></name><name><surname>Hanisch</surname><given-names>U. K.</given-names></name><name><surname>Noda</surname><given-names>M.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Physiology of microglia</article-title>. <source/>Physiol. Rev.
<volume>91</volume>, <fpage>461</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00011.2010</pub-id><pub-id pub-id-type="pmid">21527731</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Davidson</surname><given-names>J. O.</given-names></name><name><surname>Gunn</surname><given-names>K. C.</given-names></name><name><surname>Phillips</surname><given-names>A. R.</given-names></name><name><surname>Green</surname><given-names>C. R.</given-names></name><name><surname>Gunn</surname><given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of hemichannels in CNS inflammation and the inflammasome pathway</article-title>. <source/>Adv. Protein Chem. Struct. Biol.
<volume>104</volume>, <fpage>1</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apcsb.2015.12.001</pub-id><pub-id pub-id-type="pmid">27038371</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klegeris</surname><given-names>A.</given-names></name><name><surname>Bissonnette</surname><given-names>C. J.</given-names></name><name><surname>McGeer</surname><given-names>P. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor</article-title>. <source/>Br. J. Pharmacol.
<volume>139</volume>, <fpage>775</fpage>–<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0705304</pub-id><pub-id pub-id-type="pmid">12813001</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koulakoff</surname><given-names>A.</given-names></name><name><surname>Mei</surname><given-names>X.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Glial connexin expression and function in the context of Alzheimer’s disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1818</volume>, <fpage>2048</fpage>–<lpage>2057</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2011.10.001</pub-id><pub-id pub-id-type="pmid">22008509</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreft</surname><given-names>M.</given-names></name><name><surname>Potokar</surname><given-names>M.</given-names></name><name><surname>Stenovec</surname><given-names>M.</given-names></name><name><surname>Pangrsic</surname><given-names>T.</given-names></name><name><surname>Zorec</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Regulated exocytosis and vesicle trafficking in astrocytes</article-title>. <source/>Ann. N Y Acad. Sci.
<volume>1152</volume>, <fpage>30</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2008.04005.x0</pub-id><pub-id pub-id-type="pmid">19161374</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitzer</surname><given-names>A. C.</given-names></name><name><surname>Regehr</surname><given-names>W. G.</given-names></name></person-group> (<year>2001</year>). <article-title>Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells</article-title>. <source/>Neuron
<volume>29</volume>, <fpage>717</fpage>–<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(01)00246-x</pub-id><pub-id pub-id-type="pmid">11301030</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitzer</surname><given-names>A. C.</given-names></name><name><surname>Regehr</surname><given-names>W. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Retrograde signaling by endocannabinoids</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>12</volume>, <fpage>324</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/s0959-4388(02)00328-8</pub-id><pub-id pub-id-type="pmid">12049940</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglia and macrophages in brain homeostasis and disease</article-title>. <source/>Nat. Rev. Immunol. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1038/nri.2017.125</pub-id><pub-id pub-id-type="pmid">29151590</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebmann</surname><given-names>M.</given-names></name><name><surname>Stahr</surname><given-names>A.</given-names></name><name><surname>Guenther</surname><given-names>M.</given-names></name><name><surname>Witte</surname><given-names>O. W.</given-names></name><name><surname>Frahm</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Astrocytic Cx43 and Cx30 differentially modulate adult neurogenesis in mice</article-title>. <source/>Neurosci. Lett.
<volume>545</volume>, <fpage>40</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.04.013</pub-id><pub-id pub-id-type="pmid">23618652</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locovei</surname><given-names>S.</given-names></name><name><surname>Scemes</surname><given-names>E.</given-names></name><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Spray</surname><given-names>D. C.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Pannexin1 is part of the pore forming unit of the P2X<sub>7</sub> receptor death complex</article-title>. <source/>FEBS Lett.
<volume>581</volume>, <fpage>483</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2006.12.056</pub-id><pub-id pub-id-type="pmid">17240370</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locovei</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium</article-title>. <source/>FEBS Lett.
<volume>580</volume>, <fpage>239</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2005.12.004</pub-id><pub-id pub-id-type="pmid">16364313</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>Z. Y.</given-names></name><name><surname>Zhao</surname><given-names>C. B.</given-names></name><name><surname>Xiao</surname><given-names>B. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist</article-title>. <source/>J. Neurosci. Res.
<volume>90</volume>, <fpage>84</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22721</pub-id><pub-id pub-id-type="pmid">21922514</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H. C.</given-names></name><name><surname>Mackie</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>An introduction to the endogenous cannabinoid system</article-title>. <source/>Biol. Psychiatry
<volume>79</volume>, <fpage>516</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.07.028</pub-id><pub-id pub-id-type="pmid">26698193</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchicchi</surname><given-names>A.</given-names></name><name><surname>Pistis</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids</article-title>. <source/>Mol. Neurobiol.
<volume>46</volume>, <fpage>374</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-012-8299-0</pub-id><pub-id pub-id-type="pmid">22801993</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyman</surname><given-names>W. D.</given-names></name><name><surname>Sonett</surname><given-names>J. R.</given-names></name><name><surname>Brosnan</surname><given-names>C. F.</given-names></name><name><surname>Elkin</surname><given-names>R.</given-names></name><name><surname>Bornstein</surname><given-names>M. B.</given-names></name></person-group> (<year>1989</year>). <article-title>Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis</article-title>. <source/>J. Neuroimmunol.
<volume>23</volume>, <fpage>73</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/0165-5728(89)90075-1</pub-id><pub-id pub-id-type="pmid">2542370</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahvan</surname><given-names>T. D.</given-names></name><name><surname>Hilaire</surname><given-names>M. L.</given-names></name><name><surname>Mann</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name><name><surname>Linn</surname><given-names>B.</given-names></name><name><surname>Gardner</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Marijuana use in the elderly: implications and considerations</article-title>. <source/>Consult. Pharm.
<volume>32</volume>, <fpage>341</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.4140/TCP.n.2017.341</pub-id><pub-id pub-id-type="pmid">28595684</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Eugenin</surname><given-names>E. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of connexin and pannexin containing channels in HIV infection and NeuroAIDS</article-title>. <source/>Neurosci. Lett. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.neulet.2017.09.005</pub-id><pub-id pub-id-type="pmid">28886986</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchalant</surname><given-names>Y.</given-names></name><name><surname>Rosi</surname><given-names>S.</given-names></name><name><surname>Wenk</surname><given-names>G. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Anti-inflammatory property of the cannabinoid agonist WIN-55212–2 in a rodent model of chronic brain inflammation</article-title>. <source/>Neuroscience
<volume>144</volume>, <fpage>1516</fpage>–<lpage>1522</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.11.016</pub-id><pub-id pub-id-type="pmid">17178196</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrs</surname><given-names>W. R.</given-names></name><name><surname>Blankman</surname><given-names>J. L.</given-names></name><name><surname>Horne</surname><given-names>E. A.</given-names></name><name><surname>Thomazeau</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>Y. H.</given-names></name><name><surname>Coy</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>951</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2601</pub-id><pub-id pub-id-type="pmid">20657592</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsicano</surname><given-names>G.</given-names></name><name><surname>Wotjak</surname><given-names>C. T.</given-names></name><name><surname>Azad</surname><given-names>S. C.</given-names></name><name><surname>Bisogno</surname><given-names>T.</given-names></name><name><surname>Rammes</surname><given-names>G.</given-names></name><name><surname>Cascio</surname><given-names>M. G.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>The endogenous cannabinoid system controls extinction of aversive memories</article-title>. <source/>Nature
<volume>418</volume>, <fpage>530</fpage>–<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1038/nature00839</pub-id><pub-id pub-id-type="pmid">12152079</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>M.</given-names></name><name><surname>Galli</surname><given-names>T.</given-names></name><name><surname>Baux</surname><given-names>G.</given-names></name><name><surname>Mothet</surname><given-names>J. P.</given-names></name></person-group> (<year>2008</year>). <article-title>Confocal imaging and tracking of the exocytotic routes for D-serine-mediated gliotransmission</article-title>. <source/>Glia
<volume>56</volume>, <fpage>1271</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20696</pub-id><pub-id pub-id-type="pmid">18615566</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>T.</given-names></name><name><surname>Puyal</surname><given-names>J.</given-names></name><name><surname>Knolhoff</surname><given-names>A. M.</given-names></name><name><surname>Dulong</surname><given-names>J.</given-names></name><name><surname>Gasnier</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Storage and uptake of D-serine into astrocytic synaptic-like vesicles specify gliotransmission</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>3413</fpage>–<lpage>3423</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3497-12.2013</pub-id><pub-id pub-id-type="pmid">23426669</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martín-Moreno</surname><given-names>A. M.</given-names></name><name><surname>Brera</surname><given-names>B.</given-names></name><name><surname>Spuch</surname><given-names>C.</given-names></name><name><surname>Carro</surname><given-names>E.</given-names></name><name><surname>García-García</surname><given-names>L.</given-names></name><name><surname>Delgado</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-8</pub-id><pub-id pub-id-type="pmid">22248049</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>L. A.</given-names></name><name><surname>Lolait</surname><given-names>S. J.</given-names></name><name><surname>Brownstein</surname><given-names>M. J.</given-names></name><name><surname>Young</surname><given-names>A. C.</given-names></name><name><surname>Bonner</surname><given-names>T. I.</given-names></name></person-group> (<year>1990</year>). <article-title>Structure of a cannabinoid receptor and functional expression of the cloned cDNA</article-title>. <source/>Nature
<volume>346</volume>, <fpage>561</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1038/346561a0</pub-id><pub-id pub-id-type="pmid">2165569</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mecha</surname><given-names>M.</given-names></name><name><surname>Feliu</surname><given-names>A.</given-names></name><name><surname>Carrillo-Salinas</surname><given-names>F. J.</given-names></name><name><surname>Rueda-Zubiaurre</surname><given-names>A.</given-names></name><name><surname>Ortega-Gutiérrez</surname><given-names>S.</given-names></name><name><surname>de Sola</surname><given-names>R. G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Endocannabinoids drive the acquisition of an alternative phenotype in microglia</article-title>. <source/>Brain Behav. Immun.
<volume>49</volume>, <fpage>233</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.06.002</pub-id><pub-id pub-id-type="pmid">26086345</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Même</surname><given-names>W.</given-names></name><name><surname>Calvo</surname><given-names>C. F.</given-names></name><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Amigou</surname><given-names>E.</given-names></name><name><surname>Koulakoff</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by β-amyloid</article-title>. <source/>FASEB J.
<volume>20</volume>, <fpage>494</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1096/fj.05-4297fje</pub-id><pub-id pub-id-type="pmid">16423877</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metna-Laurent</surname><given-names>M.</given-names></name><name><surname>Marsicano</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors</article-title>. <source/>Glia
<volume>63</volume>, <fpage>353</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22773</pub-id><pub-id pub-id-type="pmid">25452006</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meunier</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Yi</surname><given-names>C.</given-names></name><name><surname>Dallerac</surname><given-names>G.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Koulakoff</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Contribution of astroglial Cx43 hemichannels to the modulation of glutamatergic currents by D-serine in the mouse prefrontal cortex</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>9064</fpage>–<lpage>9075</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2204-16.2017</pub-id><pub-id pub-id-type="pmid">28821660</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>R.</given-names></name><name><surname>Nevian</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Astrocyte signaling controls spike timing-dependent depression at neocortical synapses</article-title>. <source/>Nat. Neurosci.
<volume>15</volume>, <fpage>746</fpage>–<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3075</pub-id><pub-id pub-id-type="pmid">22446881</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moldrich</surname><given-names>G.</given-names></name><name><surname>Wenger</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study</article-title>. <source/>Peptides
<volume>21</volume>, <fpage>1735</fpage>–<lpage>1742</lpage>. <pub-id pub-id-type="doi">10.1016/s0196-9781(00)00324-7</pub-id><pub-id pub-id-type="pmid">11090929</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Holgado</surname><given-names>F.</given-names></name><name><surname>Molina-Holgado</surname><given-names>E.</given-names></name><name><surname>Guaza</surname><given-names>C.</given-names></name><name><surname>Rothwell</surname><given-names>N. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures</article-title>. <source/>J. Neurosci. Res.
<volume>67</volume>, <fpage>829</fpage>–<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10165</pub-id><pub-id pub-id-type="pmid">11891798</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Holgado</surname><given-names>F.</given-names></name><name><surname>Pinteaux</surname><given-names>E.</given-names></name><name><surname>Moore</surname><given-names>J. D.</given-names></name><name><surname>Molina-Holgado</surname><given-names>E.</given-names></name><name><surname>Guaza</surname><given-names>C.</given-names></name><name><surname>Gibson</surname><given-names>R. M.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>6470</fpage>–<lpage>6474</lpage>. <pub-id pub-id-type="pmid">12878687</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Holgado</surname><given-names>E.</given-names></name><name><surname>Vela</surname><given-names>J. M.</given-names></name><name><surname>Arévalo-Martín</surname><given-names>A.</given-names></name><name><surname>Almazán</surname><given-names>G.</given-names></name><name><surname>Molina-Holgado</surname><given-names>F.</given-names></name><name><surname>Borrell</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling</article-title>. <source/>J. Neurosci.
<volume>22</volume>, <fpage>9742</fpage>–<lpage>9753</lpage>. <pub-id pub-id-type="pmid">12427829</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montero</surname><given-names>T. D.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Hemichannels: new pathways for gliotransmitter release</article-title>. <source/>Neuroscience
<volume>286</volume>, <fpage>45</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.11.048</pub-id><pub-id pub-id-type="pmid">25475761</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>K. B.</given-names></name><name><surname>O’Brien</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Connexins in neurons and glia: targets for intervention in disease and injury</article-title>. <source/>Neural Regen. Res.
<volume>10</volume>, <fpage>1013</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.160092</pub-id><pub-id pub-id-type="pmid">26330808</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>S.</given-names></name><name><surname>Thomas</surname><given-names>K. L.</given-names></name><name><surname>Abu-Shaar</surname><given-names>M.</given-names></name></person-group> (<year>1993</year>). <article-title>Molecular characterization of a peripheral receptor for cannabinoids</article-title>. <source/>Nature
<volume>365</volume>, <fpage>61</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/365061a0</pub-id><pub-id pub-id-type="pmid">7689702</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete</surname><given-names>M.</given-names></name><name><surname>Araque</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Endocannabinoids mediate neuron-astrocyte communication</article-title>. <source/>Neuron
<volume>57</volume>, <fpage>883</fpage>–<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.01.029</pub-id><pub-id pub-id-type="pmid">18367089</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete</surname><given-names>M.</given-names></name><name><surname>Araque</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes</article-title>. <source/>Neuron
<volume>68</volume>, <fpage>113</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.08.043</pub-id><pub-id pub-id-type="pmid">20920795</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete</surname><given-names>M.</given-names></name><name><surname>Perea</surname><given-names>G.</given-names></name><name><surname>Fernandez de Sevilla</surname><given-names>D.</given-names></name><name><surname>Gómez-Gonzalo</surname><given-names>M.</given-names></name><name><surname>Núñez</surname><given-names>A.</given-names></name><name><surname>Martín</surname><given-names>E. D.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Astrocytes mediate <italic>in vivo</italic> cholinergic-induced synaptic plasticity</article-title>. <source/>PLoS Biol.
<volume>10</volume>:<fpage>e1001259</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1001259</pub-id><pub-id pub-id-type="pmid">22347811</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>G.</given-names></name><name><surname>Borroto-Escuela</surname><given-names>D.</given-names></name><name><surname>Angelats</surname><given-names>E.</given-names></name><name><surname>Etayo</surname><given-names>I.</given-names></name><name><surname>Reyes-Resina</surname><given-names>I.</given-names></name><name><surname>Pulido-Salgado</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia</article-title>. <source/>Brain Behav. Immun.
<volume>67</volume>, <fpage>139</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.08.015</pub-id><pub-id pub-id-type="pmid">28843453</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmrich</surname><given-names>V.</given-names></name><name><surname>Gross</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>P/Q-type calcium channel modulators</article-title>. <source/>Br. J. Pharmacol.
<volume>167</volume>, <fpage>741</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02069.x</pub-id><pub-id pub-id-type="pmid">22670568</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Núñez</surname><given-names>E.</given-names></name><name><surname>Benito</surname><given-names>C.</given-names></name><name><surname>Pazos</surname><given-names>M. R.</given-names></name><name><surname>Barbachano</surname><given-names>A.</given-names></name><name><surname>Fajardo</surname><given-names>O.</given-names></name><name><surname>González</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study</article-title>. <source/>Synapse
<volume>53</volume>, <fpage>208</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20050</pub-id><pub-id pub-id-type="pmid">15266552</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno-Shosaku</surname><given-names>T.</given-names></name><name><surname>Maejima</surname><given-names>T.</given-names></name><name><surname>Kano</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals</article-title>. <source/>Neuron
<volume>29</volume>, <fpage>729</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(01)00247-1</pub-id><pub-id pub-id-type="pmid">11301031</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira da Cruz</surname><given-names>J. F.</given-names></name><name><surname>Robin</surname><given-names>L. M.</given-names></name><name><surname>Drago</surname><given-names>F.</given-names></name><name><surname>Marsicano</surname><given-names>G.</given-names></name><name><surname>Metna-Laurent</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Astroglial type-1 cannabinoid receptor (CB1): a new player in the tripartite synapse</article-title>. <source/>Neuroscience
<volume>323</volume>, <fpage>35</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.05.002</pub-id><pub-id pub-id-type="pmid">25967266</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaivi</surname><given-names>E. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Commentary: functional neuronal CB2 cannabinoid receptors in the CNS</article-title>. <source/>Curr. Neuropharmacol.
<volume>9</volume>, <fpage>205</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.2174/157015911795017416</pub-id><pub-id pub-id-type="pmid">21886591</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaivi</surname><given-names>E. S.</given-names></name><name><surname>Ishiguro</surname><given-names>H.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>Q. R.</given-names></name></person-group> (<year>2012</year>). <article-title>CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity</article-title>. <source/>J. Psychopharmacol.
<volume>26</volume>, <fpage>92</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1177/0269881111400652</pub-id><pub-id pub-id-type="pmid">21447538</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Figueroa</surname><given-names>X. F.</given-names></name><name><surname>Sánchez</surname><given-names>H. A.</given-names></name><name><surname>Contreras-Duarte</surname><given-names>S.</given-names></name><name><surname>Velarde</surname><given-names>V.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2011a</year>). <article-title>Hemichannels in the neurovascular unit and white matter under normal and inflamed conditions</article-title>. <source/>CNS Neurol. Disord. Drug Targets
<volume>10</volume>, <fpage>404</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.2174/187152711794653869</pub-id><pub-id pub-id-type="pmid">21288190</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Jiang</surname><given-names>J. X.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><etal></etal></person-group>. (<year>2011b</year>). <article-title>ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels</article-title>. <source/>J. Neurochem.
<volume>118</volume>, <fpage>826</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07210.x</pub-id><pub-id pub-id-type="pmid">21294731</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Moraga-Amaro</surname><given-names>R.</given-names></name><name><surname>Diaz-Galarce</surname><given-names>R.</given-names></name><name><surname>Rojas</surname><given-names>S.</given-names></name><name><surname>Maturana</surname><given-names>C. J.</given-names></name><name><surname>Stehberg</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Restraint stress increases hemichannel activity in hippocampal glial cells and neurons</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>102</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00102</pub-id><pub-id pub-id-type="pmid">25883550</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Retamal</surname><given-names>M. A.</given-names></name><name><surname>Moraga-Amaro</surname><given-names>R.</given-names></name><name><surname>Stehberg</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of astroglial hemichannels and pannexons in memory and neurodegenerative diseases</article-title>. <source/>Front. Integr. Neurosci.
<volume>10</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.3389/fnint.2016.00026</pub-id><pub-id pub-id-type="pmid">27489539</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Berman</surname><given-names>J. W.</given-names></name><name><surname>Morgello</surname><given-names>S.</given-names></name><name><surname>Eugenin</surname><given-names>E. A.</given-names></name></person-group> (<year>2014</year>). <article-title>HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism</article-title>. <source/>J. Neurochem.
<volume>128</volume>, <fpage>752</fpage>–<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12492</pub-id><pub-id pub-id-type="pmid">24134157</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Sáez</surname><given-names>P. J.</given-names></name><name><surname>Cortés-Campos</surname><given-names>C.</given-names></name><name><surname>Elizondo</surname><given-names>R. J.</given-names></name><name><surname>Shoji</surname><given-names>K. F.</given-names></name><name><surname>Contreras-Duarte</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>Glucose increases intracellular free Ca<sup>2+</sup> in tanycytes via ATP released through connexin 43 hemichannels</article-title>. <source/>Glia
<volume>60</volume>, <fpage>53</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21246</pub-id><pub-id pub-id-type="pmid">21987367</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Sánchez</surname><given-names>H. A.</given-names></name><name><surname>Schalper</surname><given-names>K. A.</given-names></name><name><surname>Figueroa</surname><given-names>V.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2012b</year>). <article-title>Regulation of intercellular calcium signaling through calcium interactions with connexin-based channels</article-title>. <source/>Adv. Exp. Med. Biol.
<volume>740</volume>, <fpage>777</fpage>–<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-007-2888-2_34</pub-id><pub-id pub-id-type="pmid">22453969</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>von Bernhardi</surname><given-names>R.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2012c</year>). <article-title>Glial hemichannels and their involvement in aging and neurodegenerative diseases</article-title>. <source/>Rev. Neurosci.
<volume>23</volume>, <fpage>163</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1515/revneuro-2011-0065</pub-id><pub-id pub-id-type="pmid">22499675</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Sáez</surname><given-names>P. J.</given-names></name><name><surname>Shoji</surname><given-names>K. F.</given-names></name><name><surname>Schalper</surname><given-names>K. A.</given-names></name><name><surname>Palacios-Prado</surname><given-names>N.</given-names></name><name><surname>Velarde</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration</article-title>. <source/>Antioxid. Redox Signal.
<volume>11</volume>, <fpage>369</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2008.2130</pub-id><pub-id pub-id-type="pmid">18816186</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palazuelos</surname><given-names>J.</given-names></name><name><surname>Aguado</surname><given-names>T.</given-names></name><name><surname>Pazos</surname><given-names>M. R.</given-names></name><name><surname>Julien</surname><given-names>B.</given-names></name><name><surname>Carrasco</surname><given-names>C.</given-names></name><name><surname>Resel</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity</article-title>. <source/>Brain
<volume>132</volume>, <fpage>3152</fpage>–<lpage>3164</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp239</pub-id><pub-id pub-id-type="pmid">19805493</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekny</surname><given-names>M.</given-names></name><name><surname>Pekna</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Astrocyte reactivity and reactive astrogliosis: costs and benefits</article-title>. <source/>Physiol. Rev.
<volume>94</volume>, <fpage>1077</fpage>–<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00041.2013</pub-id><pub-id pub-id-type="pmid">25287860</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelegrin</surname><given-names>P.</given-names></name><name><surname>Surprenant</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</article-title>. <source/>EMBO J.
<volume>25</volume>, <fpage>5071</fpage>–<lpage>5082</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601378</pub-id><pub-id pub-id-type="pmid">17036048</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists</article-title>. <source/>Curr. Med. Chem.
<volume>17</volume>, <fpage>1360</fpage>–<lpage>1381</lpage>. <pub-id pub-id-type="doi">10.2174/092986710790980050</pub-id><pub-id pub-id-type="pmid">20166927</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities</article-title>. <source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
<volume>367</volume>, <fpage>3353</fpage>–<lpage>3363</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2011.0381</pub-id><pub-id pub-id-type="pmid">23108552</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertwee</surname><given-names>R. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Endocannabinoids and their pharmacological actions</article-title>. <source/>Handb. Exp. Pharmacol.
<volume>231</volume>, <fpage>1</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-20825-1_1</pub-id><pub-id pub-id-type="pmid">26408156</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piomelli</surname><given-names>D.</given-names></name></person-group> (<year>2003</year>). <article-title>The molecular logic of endocannabinoid signalling</article-title>. <source/>Nat. Rev. Neurosci.
<volume>4</volume>, <fpage>873</fpage>–<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1247</pub-id><pub-id pub-id-type="pmid">14595399</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>A. C.</given-names></name><name><surname>Sauer</surname><given-names>J. M.</given-names></name><name><surname>Knierman</surname><given-names>M. D.</given-names></name><name><surname>Becker</surname><given-names>G. W.</given-names></name><name><surname>Berna</surname><given-names>M. J.</given-names></name><name><surname>Bao</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>301</volume>, <fpage>1020</fpage>–<lpage>1024</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.301.3.1020</pub-id><pub-id pub-id-type="pmid">12023533</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prenderville</surname><given-names>J. A.</given-names></name><name><surname>Kelly</surname><given-names>A. M.</given-names></name><name><surname>Downer</surname><given-names>E. J.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of cannabinoids in adult neurogenesis</article-title>. <source/>Br. J. Pharmacol.
<volume>172</volume>, <fpage>3950</fpage>–<lpage>3963</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13186</pub-id><pub-id pub-id-type="pmid">25951750</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochnow</surname><given-names>N.</given-names></name><name><surname>Abdulazim</surname><given-names>A.</given-names></name><name><surname>Kurtenbach</surname><given-names>S.</given-names></name><name><surname>Wildförster</surname><given-names>V.</given-names></name><name><surname>Dvoriantchikova</surname><given-names>G.</given-names></name><name><surname>Hanske</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Pannexin1 stabilizes synaptic plasticity and is needed for learning</article-title>. <source/>PLoS One
<volume>7</volume>:<fpage>e51767</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0051767</pub-id><pub-id pub-id-type="pmid">23284764</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puffenbarger</surname><given-names>R. A.</given-names></name><name><surname>Boothe</surname><given-names>A. C.</given-names></name><name><surname>Cabral</surname><given-names>G. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells</article-title>. <source/>Glia
<volume>29</volume>, <fpage>58</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1098-1136(20000101)29:1&lt;58::aid-glia6&gt;3.3.co;2-n</pub-id><pub-id pub-id-type="pmid">10594923</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>296</volume>, <fpage>C250</fpage>–<lpage>C255</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00433.2008</pub-id><pub-id pub-id-type="pmid">18945939</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname><given-names>B. G.</given-names></name><name><surname>Blázquez</surname><given-names>C.</given-names></name><name><surname>Gómez Del Pulgar</surname><given-names>T.</given-names></name><name><surname>Guzmán</surname><given-names>M.</given-names></name><name><surname>de Ceballos</surname><given-names>M. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>1904</fpage>–<lpage>1913</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4540-04.2005</pub-id><pub-id pub-id-type="pmid">15728830</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>S.</given-names></name><name><surname>Dringen</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes</article-title>. <source/>Neurosci. Lett.
<volume>415</volume>, <fpage>45</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.12.043</pub-id><pub-id pub-id-type="pmid">17222973</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasooli-Nejad</surname><given-names>S.</given-names></name><name><surname>Palygin</surname><given-names>O.</given-names></name><name><surname>Lalo</surname><given-names>U.</given-names></name><name><surname>Pankratov</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Cannabinoid receptors contribute to astroglial Ca<sup>2+</sup>-signalling and control of synaptic plasticity in the neocortex</article-title>. <source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
<volume>369</volume>:<fpage>20140077</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2014.0077</pub-id><pub-id pub-id-type="pmid">25225106</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retamal</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Connexin and Pannexin hemichannels are regulated by redox potential</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00080</pub-id><pub-id pub-id-type="pmid">24611056</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retamal</surname><given-names>M. A.</given-names></name><name><surname>Cortés</surname><given-names>C. J.</given-names></name><name><surname>Reuss</surname><given-names>L.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>103</volume>, <fpage>4475</fpage>–<lpage>4480</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0511118103</pub-id><pub-id pub-id-type="pmid">16537412</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retamal</surname><given-names>M. A.</given-names></name><name><surname>Froger</surname><given-names>N.</given-names></name><name><surname>Palacios-Prado</surname><given-names>N.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Sáez</surname><given-names>P. J.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>13781</fpage>–<lpage>13792</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2042-07.2007</pub-id><pub-id pub-id-type="pmid">18077690</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robel</surname><given-names>S.</given-names></name><name><surname>Sontheimer</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Glia as drivers of abnormal neuronal activity</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>28</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4184</pub-id><pub-id pub-id-type="pmid">26713746</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rom</surname><given-names>S.</given-names></name><name><surname>Persidsky</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation</article-title>. <source/>J. Neuroimmune Pharmacol.
<volume>8</volume>, <fpage>608</fpage>–<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-013-9445-9</pub-id><pub-id pub-id-type="pmid">23471521</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>L.</given-names></name><name><surname>Madar</surname><given-names>A.</given-names></name><name><surname>Lacroix</surname><given-names>M. M.</given-names></name><name><surname>Yi</surname><given-names>C.</given-names></name><name><surname>Benchenane</surname><given-names>K.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Astroglial connexin 43 hemichannels modulate olfactory bulb slow oscillations</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>15339</fpage>–<lpage>15352</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0861-15.2015</pub-id><pub-id pub-id-type="pmid">26586821</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovegno</surname><given-names>M.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Role of astrocyte connexin hemichannels in cortical spreading depression</article-title>. <source/>Biochim. Biophys. Acta
<volume>1860</volume>, <fpage>216</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2017.08.014</pub-id><pub-id pub-id-type="pmid">28864364</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovegno</surname><given-names>M.</given-names></name><name><surname>Soto</surname><given-names>P. A.</given-names></name><name><surname>Sáez</surname><given-names>P. J.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>von Bernhardi</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Connexin43 hemichannels mediate secondary cellular damage spread from the trauma zone to distal zones in astrocyte monolayers</article-title>. <source/>Glia
<volume>63</volume>, <fpage>1185</fpage>–<lpage>1199</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22808</pub-id><pub-id pub-id-type="pmid">25731866</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozental</surname><given-names>R.</given-names></name><name><surname>Morales</surname><given-names>M.</given-names></name><name><surname>Mehler</surname><given-names>M. F.</given-names></name><name><surname>Urban</surname><given-names>M.</given-names></name><name><surname>Kremer</surname><given-names>M.</given-names></name><name><surname>Dermietzel</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Changes in the properties of gap junctions during neuronal differentiation of hippocampal progenitor cells</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>1753</fpage>–<lpage>1762</lpage>. <pub-id pub-id-type="pmid">9465000</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>Berthoud</surname><given-names>V. M.</given-names></name><name><surname>Branes</surname><given-names>M. C.</given-names></name><name><surname>Martinez</surname><given-names>A. D.</given-names></name><name><surname>Beyer</surname><given-names>E. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Plasma membrane channels formed by connexins: their regulation and functions</article-title>. <source/>Physiol. Rev.
<volume>83</volume>, <fpage>1359</fpage>–<lpage>1400</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00007.2003</pub-id><pub-id pub-id-type="pmid">14506308</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sáez</surname><given-names>J. C.</given-names></name><name><surname>Schalper</surname><given-names>K. A.</given-names></name><name><surname>Retamal</surname><given-names>M. A.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Shoji</surname><given-names>K. F.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name></person-group> (<year>2010</year>). <article-title>Cell membrane permeabilization via connexin hemichannels in living and dying cells</article-title>. <source/>Exp. Cell Res.
<volume>316</volume>, <fpage>2377</fpage>–<lpage>2389</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2010.05.026</pub-id><pub-id pub-id-type="pmid">20595004</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagan</surname><given-names>S.</given-names></name><name><surname>Venance</surname><given-names>L.</given-names></name><name><surname>Torrens</surname><given-names>Y.</given-names></name><name><surname>Cordier</surname><given-names>J.</given-names></name><name><surname>Glowinski</surname><given-names>J.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name></person-group> (<year>1999</year>). <article-title>Anandamide and WIN 55212–2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes</article-title>. <source/>Eur. J. Neurosci.
<volume>11</volume>, <fpage>691</fpage>–<lpage>699</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.1999.00480.x</pub-id><pub-id pub-id-type="pmid">10051770</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagredo</surname><given-names>O.</given-names></name><name><surname>González</surname><given-names>S.</given-names></name><name><surname>Aroyo</surname><given-names>I.</given-names></name><name><surname>Pazos</surname><given-names>M. R.</given-names></name><name><surname>Benito</surname><given-names>C.</given-names></name><name><surname>Lastres-Becker</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease</article-title>. <source/>Glia
<volume>57</volume>, <fpage>1154</fpage>–<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20838</pub-id><pub-id pub-id-type="pmid">19115380</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmina</surname><given-names>A. B.</given-names></name><name><surname>Morgun</surname><given-names>A. V.</given-names></name><name><surname>Kuvacheva</surname><given-names>N. V.</given-names></name><name><surname>Lopatina</surname><given-names>O. L.</given-names></name><name><surname>Komleva</surname><given-names>Y. K.</given-names></name><name><surname>Malinovskaya</surname><given-names>N. A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Establishment of neurogenic microenvironment in the neurovascular unit: the connexin 43 story</article-title>. <source/>Rev. Neurosci.
<volume>25</volume>, <fpage>97</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1515/revneuro-2013-0044</pub-id><pub-id pub-id-type="pmid">24445236</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez</surname><given-names>C.</given-names></name><name><surname>Galve-Roperh</surname><given-names>I.</given-names></name><name><surname>Rueda</surname><given-names>D.</given-names></name><name><surname>Guzmán</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes</article-title>. <source/>Mol. Pharmacol.
<volume>54</volume>, <fpage>834</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1124/mol.54.5.834</pub-id><pub-id pub-id-type="pmid">9804618</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez</surname><given-names>H. A.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><name><surname>Verselis</surname><given-names>V. K.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Metabolic inhibition increases activity of connexin-32 hemichannels permeable to Ca<sup>2+</sup> in transfected HeLa cells</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>297</volume>, <fpage>C665</fpage>–<lpage>C678</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00200.2009</pub-id><pub-id pub-id-type="pmid">19587218</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarrouilhe</surname><given-names>D.</given-names></name><name><surname>Dejean</surname><given-names>C.</given-names></name><name><surname>Mesnil</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Connexin43- and pannexin-based channels in neuroinflammation and cerebral neuropathies</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>:<fpage>320</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00320</pub-id><pub-id pub-id-type="pmid">29066951</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saura</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Microglial cells in astroglial cultures: a cautionary note</article-title>. <source/>J. Neuroinflammation
<volume>4</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-4-26</pub-id><pub-id pub-id-type="pmid">17937799</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scemes</surname><given-names>E.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Astrocyte calcium waves: what they are and what they do</article-title>. <source/>Glia
<volume>54</volume>, <fpage>716</fpage>–<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20374</pub-id><pub-id pub-id-type="pmid">17006900</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalper</surname><given-names>K. A.</given-names></name><name><surname>Sánchez</surname><given-names>H. A.</given-names></name><name><surname>Lee</surname><given-names>S. C.</given-names></name><name><surname>Altenberg</surname><given-names>G. A.</given-names></name><name><surname>Nathanson</surname><given-names>M. H.</given-names></name><name><surname>Sáez</surname><given-names>J. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Connexin 43 hemichannels mediate the Ca<sup>2+</sup> influx induced by extracellular alkalinization</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>299</volume>, <fpage>C1504</fpage>–<lpage>C1515</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00015.2010</pub-id><pub-id pub-id-type="pmid">20881238</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Nikolic</surname><given-names>L.</given-names></name><name><surname>Meunier</surname><given-names>C.</given-names></name><name><surname>Pfrieger</surname><given-names>F.</given-names></name><name><surname>Audinat</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>An autocrine purinergic signaling controls astrocyte-induced neuronal excitation</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>11280</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-11793-x</pub-id><pub-id pub-id-type="pmid">28900295</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>W. S.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Min</surname><given-names>X.</given-names></name><name><surname>Cabral</surname><given-names>G. A.</given-names></name><name><surname>Lokensgard</surname><given-names>J. R.</given-names></name><name><surname>Peterson</surname><given-names>P. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Synthetic cannabinoid WIN55,212–2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes</article-title>. <source/>Glia
<volume>49</volume>, <fpage>211</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20108</pub-id><pub-id pub-id-type="pmid">15390091</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>W. S.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Ni</surname><given-names>H. T.</given-names></name><name><surname>Rock</surname><given-names>R. B.</given-names></name><name><surname>Peterson</surname><given-names>P. K.</given-names></name></person-group> (<year>2009</year>). <article-title>WIN55,212–2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase</article-title>. <source/>J. Neuroimmune Pharmacol.
<volume>4</volume>, <fpage>244</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-009-9147-5</pub-id><pub-id pub-id-type="pmid">19214751</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shestopalov</surname><given-names>V. I.</given-names></name><name><surname>Slepak</surname><given-names>V. Z.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular pathways of pannexin1-mediated neurotoxicity</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00023</pub-id><pub-id pub-id-type="pmid">24575045</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>R. H.</given-names></name><name><surname>Wang</surname><given-names>C. Y.</given-names></name><name><surname>Yang</surname><given-names>C. M.</given-names></name></person-group> (<year>2015</year>). <article-title>NF-κB signaling pathways in neurological inflammation: a mini review</article-title>. <source/>Front. Mol. Neurosci.
<volume>8</volume>:<fpage>77</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2015.00077</pub-id><pub-id pub-id-type="pmid">26733801</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigel</surname><given-names>E.</given-names></name><name><surname>Baur</surname><given-names>R.</given-names></name><name><surname>Racz</surname><given-names>I.</given-names></name><name><surname>Marazzi</surname><given-names>J.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><name><surname>Zimmer</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>The major central endocannabinoid directly acts at GABA<sub>A</sub> receptors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>108</volume>, <fpage>18150</fpage>–<lpage>18155</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1113444108</pub-id><pub-id pub-id-type="pmid">22025726</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>W. R.</given-names></name><name><surname>de Rivero Vaccari</surname><given-names>J. P.</given-names></name><name><surname>Locovei</surname><given-names>S.</given-names></name><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Carlsson</surname><given-names>S. K.</given-names></name><name><surname>Scemes</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>The pannexin 1 channel activates the inflammasome in neurons and astrocytes</article-title>. <source/>J. Biol. Chem.
<volume>284</volume>, <fpage>18143</fpage>–<lpage>18151</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.004804</pub-id><pub-id pub-id-type="pmid">19416975</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simard</surname><given-names>M.</given-names></name><name><surname>Arcuino</surname><given-names>G.</given-names></name><name><surname>Takano</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>Q. S.</given-names></name><name><surname>Nedergaard</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Signaling at the gliovascular interface</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>9254</fpage>–<lpage>9262</lpage>. <pub-id pub-id-type="pmid">14534260</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Söhl</surname><given-names>G.</given-names></name><name><surname>Güldenagel</surname><given-names>M.</given-names></name><name><surname>Beck</surname><given-names>H.</given-names></name><name><surname>Teubner</surname><given-names>B.</given-names></name><name><surname>Traub</surname><given-names>O.</given-names></name><name><surname>Gutiérrez</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Expression of connexin genes in hippocampus of kainate-treated and kindled rats under conditions of experimental epilepsy</article-title>. <source/>Brain Res. Mol. Brain Res.
<volume>83</volume>, <fpage>44</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/s0169-328x(00)00195-9</pub-id><pub-id pub-id-type="pmid">11072094</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorge</surname><given-names>R. E.</given-names></name><name><surname>Trang</surname><given-names>T.</given-names></name><name><surname>Dorfman</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>S. B.</given-names></name><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Ritchie</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity</article-title>. <source/>Nat. Med.
<volume>18</volume>, <fpage>595</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2710</pub-id><pub-id pub-id-type="pmid">22447075</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stansley</surname><given-names>B.</given-names></name><name><surname>Post</surname><given-names>J.</given-names></name><name><surname>Hensley</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>115</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-115</pub-id><pub-id pub-id-type="pmid">22651808</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stehberg</surname><given-names>J.</given-names></name><name><surname>Moraga-Amaro</surname><given-names>R.</given-names></name><name><surname>Salazar</surname><given-names>C.</given-names></name><name><surname>Becerra</surname><given-names>A.</given-names></name><name><surname>Echeverria</surname><given-names>C.</given-names></name><name><surname>Orellana</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala</article-title>. <source/>FASEB J.
<volume>26</volume>, <fpage>3649</fpage>–<lpage>3657</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-198416</pub-id><pub-id pub-id-type="pmid">22665389</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stella</surname><given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>Cannabinoid signaling in glial cells</article-title>. <source/>Glia
<volume>48</volume>, <fpage>267</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20084</pub-id><pub-id pub-id-type="pmid">15390110</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stella</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas</article-title>. <source/>Glia
<volume>58</volume>, <fpage>1017</fpage>–<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20983</pub-id><pub-id pub-id-type="pmid">20468046</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stempel</surname><given-names>A. V.</given-names></name><name><surname>Stumpf</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>H. Y.</given-names></name><name><surname>Özdoğan</surname><given-names>T.</given-names></name><name><surname>Pannasch</surname><given-names>U.</given-names></name><name><surname>Theis</surname><given-names>A. K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus</article-title>. <source/>Neuron
<volume>90</volume>, <fpage>795</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.034</pub-id><pub-id pub-id-type="pmid">27133464</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stout</surname><given-names>C. E.</given-names></name><name><surname>Costantin</surname><given-names>J. L.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><name><surname>Charles</surname><given-names>A. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels</article-title>. <source/>J. Biol. Chem.
<volume>277</volume>, <fpage>10482</fpage>–<lpage>10488</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109902200</pub-id><pub-id pub-id-type="pmid">11790776</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suadicani</surname><given-names>S. O.</given-names></name><name><surname>Iglesias</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Dahl</surname><given-names>G.</given-names></name><name><surname>Spray</surname><given-names>D. C.</given-names></name><name><surname>Scemes</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes</article-title>. <source/>Glia
<volume>60</volume>, <fpage>1106</fpage>–<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22338</pub-id><pub-id pub-id-type="pmid">22499153</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>T.</given-names></name><name><surname>Kondo</surname><given-names>S.</given-names></name><name><surname>Sukagawa</surname><given-names>A.</given-names></name><name><surname>Nakane</surname><given-names>S.</given-names></name><name><surname>Shinoda</surname><given-names>A.</given-names></name><name><surname>Itoh</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>215</volume>, <fpage>89</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1002/biof.18</pub-id><pub-id pub-id-type="pmid">7575630</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>L. A.</given-names></name><name><surname>Bennett</surname><given-names>S. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Connexins and pannexins in neuronal development and adult neurogenesis</article-title>. <source/>BMC Cell Biol.
<volume>71</volume>:<fpage>S10</fpage>. <pub-id pub-id-type="doi">10.1186/s12860-016-0089-5</pub-id><pub-id pub-id-type="pmid">27230672</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>L. A.</given-names></name><name><surname>Sorbara</surname><given-names>C. D.</given-names></name><name><surname>Bennett</surname><given-names>S. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Pannexin 2 is expressed by postnatal hippocampal neural progenitors and modulates neuronal commitment</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>, <fpage>24977</fpage>–<lpage>24986</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.130054</pub-id><pub-id pub-id-type="pmid">20529862</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Kawanokuchi</surname><given-names>J.</given-names></name><name><surname>Kuno</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>21362</fpage>–<lpage>21368</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M600504200</pub-id><pub-id pub-id-type="pmid">16720574</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>R. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Pannexin channels and ischaemia</article-title>. <source/>J. Physiol.
<volume>593</volume>, <fpage>3463</fpage>–<lpage>3470</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2014.282426</pub-id><pub-id pub-id-type="pmid">25384783</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Dobrowolski</surname><given-names>R.</given-names></name><name><surname>Willecke</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Extracellular Ca<sup>2+</sup> acts as a mediator of communication from neurons to glia</article-title>. <source/>Sci. Signal.
<volume>5</volume>:<fpage>ra8</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.2002160</pub-id><pub-id pub-id-type="pmid">22275221</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turcotte</surname><given-names>C.</given-names></name><name><surname>Chouinard</surname><given-names>F.</given-names></name><name><surname>Lefebvre</surname><given-names>J. S.</given-names></name><name><surname>Flamand</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide and their metabolites</article-title>. <source/>J. Leukoc. Biol.
<volume>97</volume>, <fpage>1049</fpage>–<lpage>1070</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.3RU0115-021R</pub-id><pub-id pub-id-type="pmid">25877930</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vázquez</surname><given-names>C.</given-names></name><name><surname>Tolón</surname><given-names>R. M.</given-names></name><name><surname>Pazos</surname><given-names>M. R.</given-names></name><name><surname>Moreno</surname><given-names>M.</given-names></name><name><surname>Koester</surname><given-names>E. C.</given-names></name><name><surname>Cravatt</surname><given-names>B. F.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: <italic>in vivo</italic> studies</article-title>. <source/>Neurobiol. Dis.
<volume>79</volume>, <fpage>41</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.04.005</pub-id><pub-id pub-id-type="pmid">25917763</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waksman</surname><given-names>Y.</given-names></name><name><surname>Olson</surname><given-names>J. M.</given-names></name><name><surname>Carlisle</surname><given-names>S. J.</given-names></name><name><surname>Cabral</surname><given-names>G. A.</given-names></name></person-group> (<year>1999</year>). <article-title>The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>288</volume>, <fpage>1357</fpage>–<lpage>1366</lpage>. <pub-id pub-id-type="pmid">10027878</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walrave</surname><given-names>L.</given-names></name><name><surname>Vinken</surname><given-names>M.</given-names></name><name><surname>Albertini</surname><given-names>G.</given-names></name><name><surname>De Bundel</surname><given-names>D.</given-names></name><name><surname>Leybaert</surname><given-names>L.</given-names></name><name><surname>Smolders</surname><given-names>I. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Inhibition of connexin43 hemichannels impairs spatial short-term memory without affecting spatial working memory</article-title>. <source/>Front. Cell. Neurosci.
<volume>10</volume>:<fpage>288</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00288</pub-id><pub-id pub-id-type="pmid">28066184</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>L.</given-names></name><name><surname>Franklin</surname><given-names>A.</given-names></name><name><surname>Witting</surname><given-names>A.</given-names></name><name><surname>Wade</surname><given-names>C.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Kunos</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Nonpsychotropic cannabinoid receptors regulate microglial cell migration</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>1398</fpage>–<lpage>1405</lpage>. <pub-id pub-id-type="pmid">12598628</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>L.</given-names></name><name><surname>Stella</surname><given-names>N.</given-names></name></person-group> (<year>2003</year>). <article-title>Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes</article-title>. <source/>Glia
<volume>44</volume>, <fpage>85</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10270</pub-id><pub-id pub-id-type="pmid">12951660</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>De Bock</surname><given-names>M.</given-names></name><name><surname>Decrock</surname><given-names>E.</given-names></name><name><surname>Bol</surname><given-names>M.</given-names></name><name><surname>Gadicherla</surname><given-names>A.</given-names></name><name><surname>Vinken</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013a</year>). <article-title>Paracrine signaling through plasma membrane hemichannels</article-title>. <source/>Biochim. Biophys. Acta
<volume>1828</volume>, <fpage>35</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2012.07.002</pub-id><pub-id pub-id-type="pmid">22796188</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>De Vuyst</surname><given-names>E.</given-names></name><name><surname>Ponsaerts</surname><given-names>R.</given-names></name><name><surname>Boengler</surname><given-names>K.</given-names></name><name><surname>Palacios-Prado</surname><given-names>N.</given-names></name><name><surname>Wauman</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013b</year>). <article-title>Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury</article-title>. <source/>Basic Res. Cardiol
<volume>108</volume>:<fpage>309</fpage>. <pub-id pub-id-type="doi">10.1007/s00395-012-0309-x</pub-id><pub-id pub-id-type="pmid">23184389</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Xing</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Qin</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Gypenoside IX suppresses p38 MAPK/Akt/NFκB signaling pathway activation and inflammatory responses in astrocytes stimulated by proinflammatory mediators</article-title>. <source/>Inflammation
<volume>40</volume>, <fpage>2137</fpage>–<lpage>2150</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-017-0654-x</pub-id><pub-id pub-id-type="pmid">28822019</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>Ultrafine carbon black induces glutamate and ATP release by activating connexin and pannexin hemichannels in cultured astrocytes</article-title>. <source/>Toxicology
<volume>323</volume>, <fpage>32</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2014.06.005</pub-id><pub-id pub-id-type="pmid">24932759</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weilinger</surname><given-names>N. L.</given-names></name><name><surname>Tang</surname><given-names>P. L.</given-names></name><name><surname>Thompson</surname><given-names>R. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Anoxia-induced NMDA receptor activation opens pannexin channels via Src family kinases</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>12579</fpage>–<lpage>12588</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1267-12.2012</pub-id><pub-id pub-id-type="pmid">22956847</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willebrords</surname><given-names>J.</given-names></name><name><surname>Maes</surname><given-names>M.</given-names></name><name><surname>Crespo Yanguas</surname><given-names>S.</given-names></name><name><surname>Vinken</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Inhibitors of connexin and pannexin channels as potential therapeutics</article-title>. <source/>Pharmacol. Ther.
<volume>180</volume>, <fpage>144</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2017.07.001</pub-id><pub-id pub-id-type="pmid">28720428</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R. I.</given-names></name><name><surname>Nicoll</surname><given-names>R. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses</article-title>. <source/>Nature
<volume>410</volume>, <fpage>588</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1038/35069076</pub-id><pub-id pub-id-type="pmid">11279497</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yassin</surname><given-names>M.</given-names></name><name><surname>Haluza-Delay</surname><given-names>R.</given-names></name><name><surname>Kadiri</surname><given-names>M.</given-names></name><name><surname>Ouahrani</surname><given-names>A. E.</given-names></name><name><surname>Mesa</surname><given-names>J. M.</given-names></name><name><surname>Merzouki</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Cannabis cultivation within a religious context: a case study of Ghomara in the Rif Mountain (Northern Morocco)</article-title>. <source/>J. Ethn. Subst. Abuse
<volume>4</volume>, <fpage>1</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1080/15332640.2017.1300972</pub-id><pub-id pub-id-type="pmid">28375809</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z. C.</given-names></name><name><surname>Wyeth</surname><given-names>M. S.</given-names></name><name><surname>Baltan-Tekkok</surname><given-names>S.</given-names></name><name><surname>Ransom</surname><given-names>B. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Functional hemichannels in astrocytes: a novel mechanism of glutamate release</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>3588</fpage>–<lpage>3596</lpage>. <pub-id pub-id-type="pmid">12736329</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>C.</given-names></name><name><surname>Mei</surname><given-names>X.</given-names></name><name><surname>Ezan</surname><given-names>P.</given-names></name><name><surname>Mato</surname><given-names>S.</given-names></name><name><surname>Matias</surname><given-names>I.</given-names></name><name><surname>Giaume</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer’s disease</article-title>. <source/>Cell Death Differ.
<volume>23</volume>, <fpage>1691</fpage>–<lpage>1701</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2016.63</pub-id><pub-id pub-id-type="pmid">27391799</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Luo</surname><given-names>Q.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Regulated ATP release from astrocytes through lysosome exocytosis</article-title>. <source/>Nat. Cell Biol.
<volume>9</volume>, <fpage>945</fpage>–<lpage>953</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1620</pub-id><pub-id pub-id-type="pmid">17618272</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Nelson</surname><given-names>A. R.</given-names></name><name><surname>Betsholtz</surname><given-names>C.</given-names></name><name><surname>Zlokovic</surname><given-names>B. V.</given-names></name></person-group> (<year>2015</year>). <article-title>Establishment and dysfunction of the blood-brain barrier</article-title>. <source/>Cell
<volume>163</volume>, <fpage>1064</fpage>–<lpage>1078</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.10.067</pub-id><pub-id pub-id-type="pmid">26590417</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoidl</surname><given-names>G.</given-names></name><name><surname>Petrasch-Parwez</surname><given-names>E.</given-names></name><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Meier</surname><given-names>C.</given-names></name><name><surname>Bunse</surname><given-names>S.</given-names></name><name><surname>Habbes</surname><given-names>H. W.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus</article-title>. <source/>Neuroscience
<volume>146</volume>, <fpage>9</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.01.061</pub-id><pub-id pub-id-type="pmid">17379420</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuardi</surname><given-names>A. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action</article-title>. <source/>Rev. Bras. Psiquiatr.
<volume>30</volume>, <fpage>271</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1590/s1516-44462008000300015</pub-id><pub-id pub-id-type="pmid">18833429</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zygmunt</surname><given-names>P. M.</given-names></name><name><surname>Petersson</surname><given-names>J.</given-names></name><name><surname>Andersson</surname><given-names>D. A.</given-names></name><name><surname>Chuang</surname><given-names>H.</given-names></name><name><surname>Sørgård</surname><given-names>M.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide</article-title>. <source/>Nature
<volume>400</volume>, <fpage>452</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1038/22761</pub-id><pub-id pub-id-type="pmid">10440374</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>